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Background: Plantar fasciitis (PF) is one of the most common soft tissue disorders that 
causes inferior heel and rear foot pain. Monophasic pulsed current (MPC) is a method of 
electrical stimulation (ES) clinically used to promote and accelerate wound healing 
processes. The aim of this prospective clinical trial was to investigate the effect of MPC 
and MPC coupled with plantar fascia specific stretching exercises (SE) in the treatment 
of PF. 
Methods: Forty four participants (twenty- two subjects were women; 22 were men with a 
mean age of 49 ± 10.6 years) diagnosed with PF were randomly allocated to receive MPC 
(n=22) or MPC coupled with plantar fascia specific SE (n=22).  Prior to treatment, 
participants underwent a baseline evaluation. Heel pain was evaluated using the visual 
analogue scale (VAS), heel tenderness threshold was quantified using a handheld 
pressure algometer (PA), the functional activities level was assessed using the Activities 
of Daily Living subscale of the Foot and Ankle Ability Measure (ADL/FAAM), and the 
sagittal thickness (ST) of the proximal insertion of the plantar fascia was measured with 
musculoskeletal ultrasound (MSK US). Following treatment, post intervention evaluation 
was performed using the same outcome measures. 
xv 
Results:  The findings of this study demonstrated that the two groups of subjects 
experienced significant improvements in all outcome measures after treatment. First, heel 
pain scores showed statistically significant reduction in both groups compared with 
baseline VAS scores (P < 0.001). Second, heel tenderness decreased significantly in both 
groups compared with baseline PA scores (P < 0.001). Third, the functional activities 
level improved significantly in both groups of subjects compared with baseline 
(ADL/FAAM) scores (P < 0.001). ). Lastly, the ST of the proximal insertion of the 
plantar fascia decreased significantly in both groups compared with baseline MSK US 
measurements (P < 0.001).  However, no statistically significant differences between the 
two treatment groups were exhibited in all post intervention outcome measures. 
Conclusion: This trial showed the ability of MPC and MPC coupled with plantar SE to 
produce benefits for patients diagnosed with PF in terms of reducing heel pain and 
tenderness, improving the function activities level, and decreasing the ST of plantar 
fascia.  Both MPC and MPC coupled with plantar fascia SE had similar effectiveness on 
the treatment of PF. 
Keywords: plantar fasciitis, monophasic pulsed current, plantar fascia specific stretching 
exercises. 
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CHAPTER ONE 
INTRODUCTION 
 
Plantar fasciitis (PF) was first described by William Wood in 1812 and he 
attributed its presentation to tuberculosis1-3.   PF as a clinical diagnosis is known by many 
pseudonyms:  Jogger’s heel, heel spur syndrome, plantar fascial insertitis, calcaneal 
enthesopathy, subcalcaneal bursitis, subcalcaneal pain, stone bruise, calcaneal periostitis, 
neuritis and calcaneodynia4-6.   Proximal PF or plantar heel pain is the most common soft 
tissue disorder that causes inferior heel and rear foot pain in athletes as well as those not 
involved in sport activities7,8.  Proximal PF is a common clinical diagnostic entity usually 
affecting more than two million Americans every year. It constitutes approximately 15 % 
of foot dysfunction conditions in the United States, affects two million individuals, and 
accounts for more one million outpatient visits annually3,9,10.      
PF is considered to be a self-limited condition and symptoms settle in 80% to 
90% of conditions. The resolution of symptoms occurs in majority of patients within ten 
months with conservative treatment2,7,11.   PF can be a painful, debilitating, and disabling 
condition that often frustrates not only the patient but also the physician because its 
etiology is still equivocal3,8,12,13.    PF is also considered to be an overuse syndrome and 
an inflammatory reaction from chronic irritation or microtears of proximal plantar fascia 
at its attachment at the medial tuberosity of the calcaneus2,14.   
PF is defined as a localized inflammation of perifascial anatomical structures and 
plantar fascia at its proximal insertion on the medial tuberosity of the calcaneus resulting 
2 
from chronic repetitive microtears and degeneration secondary to overuse, mechanical 
and congenital disorders3,7-10,15.  PF is also clinically defined as inferior heel pain and 
tenderness of gradual onset, localized to the medial tuberosity of the calcaneus and 
exacerbated by weight bearing11,16.  It can affect patients from childhood to older ages, 
but is most common in middle aged women and young athletes. Inflammation of the 
plantar fascia is prevalent in joggers, long distance runners and tennis players as well as 
soccer players, gymnasts, volleyball and basketball players7,8,17.   PF is also common in 
overweight individuals with occupations that require extensive standing or weight 
bearing8,18,19.   
Plantar fascia or plantar aponeurosis is a thick and strong fibrous connective 
tissue which originates at the medial tuberosity of the calcaneus and fans out distally into 
three bands to attach into the bases of proximal phalanges or at the metatarsophalangeal 
joints to form the medial longitudinal arch of the foot11,18.   Plantar fascia lies superficial 
to the muscles of the plantar surface of the foot and divides into three portions: central or 
middle, lateral, and medial. The central or middle portion is considered to be the thickest 
component of the plantar fascia, and originates from the posterior aspect of the medial 
tuberosity of the calcaneus posterior to the origin of the flexor digitorum brevis tendon, 
and is its width is between 1.5 to 2.0 cm.  Distally, at the level of the metatarsophalangeal 
joints, the central portion of the plantar aponeurosis divides in to five bands, one for each 
of the toes3,20-24.     
 The lateral component of the plantar aponeurosis originates from the lateral aspect 
of the medial tuberosity of the calcaneus with its distal medial and lateral bands 
connecting to the plantar plate of the fourth toe and to the base of the fifth metatarsal 
3 
bones, respectively.  The medial component of the plantar aponeurosis is thin and lies 
superficial to the abductor hallucis muscle and connected medially with the dorsal fascia 
and laterally with the central component of the plantar aponeurosis3,18,20,21,23,25.            
Histological examination of biopsy samples  of the irritated  and inflamed plantar  
fascia reveal granulation tissue, fibroblast proliferation, and fibrosis, collagen necrosis, 
chondroid metaplasia, and matrix calcification, all of which are suggestive of a repetitive 
strain and fascia degenerative process26,27.   
The windlass mechanism is a term used to explain the responsibility of the plantar 
fascia dynamic function during a manner of walking28.  The plantar fascia functions 
through the windlass mechanism which was described first by Hicks as a mechanical 
model29,30.  The plantar fascia plays an important role in providing support for the foot 
through the stance phase of gait cycle.  During the toe off of phase the gait cycle, the 
extension of the toes at the metatarsophalangeal joints tightens the planter fascia and 
elevates the medial longitudinal arch, thus forming a solid pivot of the foot for push 
off30,31.   The foot and its ligaments can be thought of as a truss or arch-like triangular 
structure, with the calcaneus, midtarsal joint, and metatarsals forming the medial 
longitudinal arch28,29.  
The etiology of PF remains unclear and is poorly understood and is still debated 
among medical fraternity despite its high prevalence3,7,11.  Even the etiology of PF is 
poorly established in previous research literature, it is thought to be caused by intrinsic 
and extrinsic predisposing factors11,32.  Intrinsic precipitating factors that may make an 
individual vulnerable for the development of PF may include obesity and a body mass 
index of more than 30. Being overweight can increase stress upon plantar fascia during 
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normal walking.  Secondly, advanced age can predispose an individual to PF.  After the 
age of 40 years, the fat pad begins to degenerate, with loss of water content and collagen 
component that affects it elasticity. When sagittal thickness of the fat pad decreases, it 
may result in minimizing shock absorbency of that anatomical structure and reduced 
protection of the calcaneal tuberosity and plantar fascia.  Thirdly, Achilles tendon 
tightness and inadequate ankle dorsiflexion may lead to excessive subtalar pronation and 
thus contributes to plantar fascia elongation and irritation.  Fourthly, excessive pronation 
(pes planus) is caused by plantar flexion and adduction of talus and can cause the height 
of the longitudinal arch of the foot to decrease and create strain on the plantar 
aponeurosis which can result in the development of plantar fasciitis7,10,11,33.   Other 
intrinsic potential risk factors may include leg length discrepancy, excessive lateral tibial 
torsion, and excessive femoral anteversion, pes cavus and equinus, and sudden weight 
gain7,8,11 
Potential extrinsic potential predisposing factors that may make someone 
susceptible for the development of plantar fasciitis may include high intensity sport 
activities or training that require repetitive plantar flexion of the ankle joint and extension 
of the metatarsophalangeal joints and that mechanical overload and excessive tensile load 
produce microtears within the plantar fascia, which eventually incites a chronic 
inflammatory response followed by degeneration8,33,34. Other extrinsic potential risk 
factors include the use of poor or worn footwear, occupational and recreational activities 
that require prolonged standing or weight bearing, and improper training techniques7,11,32.     
The classic feature and presentation of PF are mechanical symptoms of pain on 
the sole of the foot at the inferior region of the heel32,33.   The onset of the inferior heel 
5 
pain is insidious and may worsen over time.  Heel pain may interfere with walking, 
particularly when first taking the first few steps in the morning after getting out of the 
bed, or weightbearing after prolonged sitting or inactivity.  The intense and shooting 
inferior heel pain can be so terrible that the patient may limp around with the affected 
heel off the ground.  By the end of the day, a dull aching pain typically occurs and may 
extend to the midfoot and forefoot.  The sharp pain is usually localized to the 
plantarmedial aspect of the heel or over a small area near the proximal insertion of the 
plantar fascia at the medial tuberosity of the calcaneus3,18,19,26,32,33,35.   
The diagnosis of PF can be made through a thorough and comprehensive history 
taking and physical examinations.  Heel pain, while taking first steps in the morning, is 
typical of plantar fasciitis and presents differently from other inferior heel pain 
dysfunctions. Inferior heel pain imposed by plantar fasciitis is associated with paresthesia 
or nocturnal pain. Localized tenderness to palpation of plantar fascia at its origin on the 
anteromedial aspect of the calcaneal tuberosity may be elicited by slight passive 
dorsiflexion of the toes or having the patient stand on the tips of the toes.  A windlass test 
is considered to be positive when passive dorsiflexion of the hallux reproduces pain and 
discomfort at the proximal plantar fascia. The evaluation of range of motion may reveal 
or demonstrate a restriction of ankle dorsiflexion by 5 degrees or more which indicates 
contracture of the Achilles tendon3,8,11,25,36.     
A plain radiograph does not support the diagnosis of PF but can be used to look 
for bony lesions of the foot.  Diagnostic ultrasonography is inexpensive and useful in 
ruling out soft tissue pathology of the heel.  Findings of diagnostic ultrasound that verify 
the presence of PF fasciitis include proximal plantar fascia thickness greater than 4 mm 
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and areas of hypoechogenicity.  Magnetic resonance imaging, although expensive, is also 
a valuable tool for assessing causes of recalcitrant heel pain11,18,21,37,38.  Diagnostic 
findings include increased proximal plantar fascia thickening with increased signal 
intensity on T2-weighted imaging11,18,26,39.  Differential diagnosis of plantar fasciitis 
includes calcaneal stress fractures, osteomyelitis, tumor, sacral radiculopathy, Reiter's 
syndrome, Sever's disease, psoriatic arthritis, ankylosing spondylitis, tarsal tunnel 
syndrome, foreign body, and nerve entrapments7,8,11,34.     
The treatment of PF is primarily conservative. It is commonly treated with 
nonsteroidal anti-inflammatory medications, physical therapy, and corticosteroid 
injections. If conservative treatment fails, surgical option may be indicated1,3,7,11.     
Physical therapy plays a significant role in the treatment of PF32.  Many physical 
therapy treatment options are available which may mitigate and allay the heel pain 
symptoms associated with PF besides rest and avoiding any strenuous and arduous 
activities that place strain on the inflamed and irritated proximal insertion of plantar 
fascia9,10,40,41.  
In 2008, the orthopedic section of the American Physical Therapy Association 
(APTA) began issuing a series of evidence based clinical practice guidelines linked to the 
international classification of function, disability, and health that gives recommendations 
about assessment, prognosis, diagnosis, and treatment for common musculoskeletal 
dysfunctions.  In terms of plantar fasciitis, there are many physical therapy interventions 
or means that can be used to alleviate and attenuate the inferior heel symptoms that are 
associated with PF,42. These modalities include iontophoresis, manual therapy, night 
splinting, prefabricated and customized insets, shoe modification, stretching exercises of 
7 
calf muscles and plantar fascia, taping, orthotic devices, which can be used to suit patient 
needs9-11,32,33,40-49. Other physical therapy techniques may include soft tissue mobilization, 
heel padding, icing, contrast baths, ultrasound, and rest34,50,51.   
Monophasic pulsed current (MPC) is utilized clinically to promote wound and 
pressure ulcer healing processes.  Delivering of electrical current using electrodes to 
wound bed seems to induce cellular actions and histological responses such as collagen 
and deoxyribonucleic acid synthesis, adenosine triphosphate production, increase the 
number of growth factor receptor, and calcium influx. Vitro studies showed that key 
tissue cells such epithelial and fibroblast cells have been attracted to wound site when 
electrically stimulated resulting in promoting collagen deposition, angiogenesis and 
wound tensile strength.  Many studies inferred that wounds treated with MPC 
demonstrated 1.5 times greater rate of healing when compared to normal wound healing 
rates52-59.  MPC is defined as percutaneous delivery of pulsed, twin-peak, monophasic 
pulses, each pulse having very short phase duration of less than 100 μsec, which employs 
voltage up to 500 volts 52-54.  Galvanotaxis is one of the MCP features and is defined as 
the process of attracting charged cells to an electric field of opposite polarity. Clinically 
in treating wounds or decubitus ulcers, a positively charged electrode (anode) is placed 
over a wound or ulcer, to attract negatively charged cells such as neutrophils and 
macrophages to facilitate the inflammatory phase of wound healing.  Plantar fascia is a 
connective tissue. The fibroblast cells’ main function in connective tissue is to maintain 
its structural integrity. Fibroblasts are the key cells during the proliferation phase of 
fascia healing. Fibroblasts make the collagens, glycosaminoglycans, elastin fibers, and 
glycoproteins found in the extracellular matrix53,56,57,60. Because polarity selection is 
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based on the healing phase the practitioner wishes to facilitate and accelerate, we used the 
negatively charged cathode to attract the positively charged fibroblast cells to promote 
and accelerate proliferation phase of plantar fascia. 
The primary focus of this study was to examine the effect of MPC and MPC 
coupled with plantar fascia-stretching exercises (SE) on inferior heel symptoms caused 
by PF. Chapter two evaluated the effect of MPC and MPC coupled with plantar fascia SE 
on the subjective reporting of heel pain, tenderness, and functional activities level caused 
by PF. Chapter three examined the effect of MPC and MPC coupled with plantar fascia 
SE on the change of the sagittal thickness of proximal insertion of plantar fascia on 
patients diagnosed with PF.  Chapter four investigated the correlation between the change 
of heel pain scores using visual analogue scale (VAS) as a subjective outcome measure 
and the change in the sagittal thickness proximal insertion of plantar fascia using 
musculoskeletal ultrasound (MSK US) as an objective measure when investigating the 
effect of MPC and MPC coupled with plantar fascia specific SE in the treatment of PF. 
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Abstract 
Background: Plantar fasciitis (PF) is one of the most common causes of heel and 
foot pain, affecting up to 2 million Americans each year and accounting for 15% of all 
foot pathologies. Monophasic pulsed current (MPC) is a method of electrical stimulation 
(ES) clinically used to promote and accelerate wound healing processes. The aim of this 
prospective clinical trial was to investigate the effect of MPC and MPC coupled with 
plantar fascia specific stretching exercises (SE) in the treatment of plantar fasciitis 
Methods: Forty four participants (22 were women; 22 were men, with a mean age 
of 49 ± 10.6 years) diagnosed with PF were randomly allocated to receive MPC (n=22) or 
MPC coupled with plantar fascia specific stretching exercises (SE) (n=22).  Prior to each 
treatment, participants underwent baseline evaluation, heel pain was evaluated using the 
visual analogue scale (VAS), heel tenderness threshold was quantified using a handheld 
pressure algometer (PA), and the function activities level was assessed using the 
Activities of  Daily Living subscale of the Foot and Ankle Ability Measure 
(ADL/FAAM). Following treatment, post intervention evaluation was performed using 
the same outcome measures. 
Results:  This study demonstrated that the two groups experienced significant 
improvement in all outcome measures after treatment. First, heel pain scores showed a 
significant reduction in both groups compared with baseline VAS scores (P < 0.001). 
Second, heel tenderness decreased significantly in both groups compared with baseline 
PA scores (P < 0.001). Lastly, functional activities levels improved significantly in both 
groups compared with baseline (ADL/FAAM) scores (P< 0.001).  However, no 
significant differences existed between the two treatment groups in all post intervention 
outcome measures. 
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Conclusion: This trial showed the capacity of MPC to reduce heel pain and 
tenderness, while improving functional activities levels associated with PF. Both MPC 
and MPC coupled with plantar fascia SE had similar effectiveness on the treatment of PF. 
Keywords: plantar fasciitis, monophasic pulsed current, plantar fascia specific stretching 
exercise 
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Introduction 
Plantar fasciitis (PF) is a soft tissue disorder first described by William Wood in 
1812 and he linked its presentation to infectious diseases such as tuberculosis1-3.  PF is 
often misdiagnosed under the auspices of  jogger’s heel, heel spur syndrome, plantar 
fascial insertitis, calcaneal enthesopathy, subcalcaneal bursitis, subcalcaneal pain, stone 
bruise, calcaneal periostitis, neuritis and calcaneodynia4,5 6. PF is the most common soft 
tissue dysfunction that causes inferior heel pain in athletes as well as sedentary adults7,8.  
PF is a common diagnostic entity affecting more than two million Americans every year1-
3. It constitutes approximately 15 % of foot dysfunctions in the United States and 
accounts for more than one million outpatient visits each year3,9,10.     
PF symptoms resolve in 90% of cases and resolution of symptoms occurs in the 
majority of patients within ten months of conservative treatment7,11,12.  PF can be a 
painful and disabling disorder that often frustrates not only the patient but also the 
physician because its etiology is still equivocal3,8,13,14. 
PF is presumed to be an inflammatory reaction from chronic irritation or 
microtears of proximal plantar fascia at its attachment at the medial tuberosity of the 
calcaneus2,15.  It can be defined as a localized inflammation of perifascial structures and 
plantar fascia at proximal attachment on the medial tuberosity of the calcaneus resulting 
from chronic repetitive microtears and degeneration secondary to overuse, mechanical 
and congenital disorders 3,7-10,12.  
PF is also clinically defined as inferior heel pain and tenderness of gradual onset, 
localized to medial tuberosity of the calcaneus and exacerbated by weight bearing 11,16.  It 
can affect patients from childhood to older adults, but is most common in middle aged 
women and young athletes. Inflammation of the plantar fascia is prevalent in athletes 
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such as  joggers, long distance runners and tennis players as well as soccer players, 
gymnasts, volleyball and basketball players 7,8,17.  PF is also common in overweight 
individuals with occupations which require extensive standing8,18 19. 
Plantar fascia or plantar aponeurosis is a thick and strong fibrous connective 
tissue which originates at the medial tuberosity of the calcaneus and fans out distally into 
three bands to attach into the bases of proximal phalanges or at the metatarsophalangeal 
joints to form the medial longitudinal arch of the foot 11,18.  Plantar fascia lies superficial 
to the muscles of the plantar surface of the foot and divides into three portions: central or 
middle, lateral, and medial. The central or middle portion is considered to be the thickest 
component of the plantar fascia, and originates from the posterior aspect of the medial 
tuberosity of the calcaneus posterior to the origin of the flexor digitorum brevis tendon, 
and is its width is between 1.5 to 2.0 cm.  Distally, at the level of the metatarsophalangeal 
joints, the central portion of the plantar aponeurosis divides in to five bands, one for each 
of the toes3,20-24.                 
 The lateral component of the plantar aponeurosis originates from the lateral aspect 
of the medial tuberosity of the calcaneus with its distal medial and lateral bands 
connecting to the plantar plate of the fourth toe and to the base of the fifth metatarsal 
bones respectively.  The medial component of the plantar aponeurosis is thin and lies 
superficial to the abductor hallucis muscle and connected medially with the dorsal fascia 
and laterally with the central component of the plantar aponeurosis 3,10,18,20,21,23. 
Histological examination of the irritated  and inflamed plantar  fascia reveal 
granulation tissue, fibroblast proliferation, and fibrosis , collagen necrosis, chondroid 
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metaplasia, and matrix calcification, all of which are suggestive of repetitive strain and 
fascia degeneration25,26.  
The windlass mechanism model is a term used to explain the responsibility of the 
plantar fascia dynamic function during a manner of walking27. The plantar fascia 
functions through the windlass mechanism which was described first by Hicks as a 
mechanical model25,28.  The plantar fascia plays an important role in providing support 
for the foot through the stance phase of gait cycle. During the toe off of the gait cycle, the 
extension of the toes at the metatarsophalangeal joints tightens the planter fascia and 
elevates the medial longitudinal arch thus forming a solid pivot of foot for the push off 
28,29.  The foot and its ligaments can be thought of as a truss or arch-like triangular 
structure, with the calcaneus, midtarsal joint, and metatarsals forming the medial 
longitudinal arch25,27. 
The etiology of PF is unclear. It is poorly understood and still debated among 
medical fraternity3,7,11.  Even the etiology of plantar fasciitis is poorly established in 
previous research; it is thought to be caused by intrinsic and extrinsic predisposing risk 
factors11,30.  Intrinsic precipitating factors that may make an individual vulnerable for the 
development of plantar fasciitis include obesity and a body mass index of more than 30. 
Being overweight can increase stress upon plantar fascia during normal walking.  
Secondly, advanced age can predispose an individual to plantar fasciitis.  After the age of 
40 years, the fat pad begins to degenerate, with loss of water content and collagen 
component that affects it elasticity.  When sagittal thickness of the fat pad decreases, it 
minimizes shock absorbency of that anatomical structure and reduced protection of the 
calcaneal tuberosity and plantar fascia.  Thirdly, Achilles tendon tightness and inadequate 
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ankle dorsiflexion can lead to excessive subtalar pronation to compensate for that 
dysfunction and over pronation contributes to plantar fascia elongation and overstretch.  
Fourthly, excessive foot pronation (pes planus) is caused by plantar flexion and adduction 
of talus and can cause the height longitudinal arch of the foot to decrease and create strain 
on the plantar aponeurosis which can result in the development of plantar fasciitis7,10,11,31.  
Other intrinsic potential risk factors may include leg length discrepancy, excessive lateral 
tibial torsion, and excessive femoral anteversion, pes cavus and equinus, and sudden 
weight gain7,8,11. 
Extrinsic potential predisposing factors that may make someone susceptible to 
developing plantar fasciitis include high intensity sport activities or training that require 
repetitive plantar flexion of the ankle joint and extension of the metatarsophalangeal 
joints and that mechanical overload and excessive tensile load that produce microtears 
within the plantar fascia, which eventually incites a chronic inflammatory response 
followed by degeneration8,31,32. 
Other extrinsic potential risk factors include use poor or worn footwear, occupational and 
recreational activities which require prolonged weight bearing, and improper training 
techniques7,11,30. 
The classic feature and presentation of PF are mechanical symptoms of pain on 
the sole of the foot at the inferior region of the heel30,31.  The onset of the inferior heel 
pain is insidious and may worsen over time. Pain may interfere with walking, particularly 
when taking the first few steps in the morning after getting out of the bed, or 
weightbearing after a period of prolonged sitting or inactivity.  The intense and shooting 
inferior heel pain can be so intense that the patient may limp around with the affected 
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heel off the ground.  By the end of the day, a dull aching pain typically occurs and may 
extend to the midfoot and forefoot.  The sharp pain is usually localized to the 
plantarmedial aspect of the heel or over a small area near the proximal insertion of the 
plantar fascia at the medial tuberosity of the calcaneus3,18,26,30,31,33. 
The diagnosis of PF can be made through a comprehensive history taking and 
physical examination.  Heel pain, while taking first steps in the morning, is typical of 
plantar fasciitis and will reveal differences from other inferior heel pain dysfunctions. 
Inferior heel pain imposed by PF does not accompany paresthesia or nocturnal pain. 
Localized tenderness of plantar fascia at its origin on anteromedial aspect of the calcaneal 
tuberosity may be elicited by slight passive dorsiflexion of the toes or having the patient 
stands on the tips of the toes.  A windlass test is considered to be positive when passive 
dorsiflexion of the hallux reproduces pain and discomfort at the proximal plantar fascia. 
Range of motion assessment may demonstrate a restriction of ankle dorsiflexion by 5 
degrees or more which indicates contracture of the Achilles tendon3,8,11,34,35.      
A plain radiograph does not support the diagnosis of PF but can be used to look 
for bony lesions of the foot.  Diagnostic ultrasonography is inexpensive and useful in 
ruling out soft tissue pathology of the heel.  Findings of diagnostic ultrasound that 
support the presence of PF include proximal plantar fascia thickness greater than 4 mm 
and areas of hypoechogenicity.  Magnetic resonance imaging, although expensive, is a 
valuable tool for assessing causes of recalcitrant heel pain11,18,21,36,37.  Diagnostic findings 
include abnormal proximal plantar fascia thickening with increased signal intensity on 
T2-weighted imaging11,18,26,38. 
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 PF needs to be differentiated from diagnoses and diseases that cause inferior heel 
pain such as calcaneal stress fractures, osteomyelitis, tumor, sacral radiculopathy, Reiter's 
syndrome, Sever's disease, psoriatic arthritis, ankylosing spondylitis, tarsal tunnel 
syndrome, foreign body, and nerve entrapments7,8,11,39.  
The treatment of PF is primarily conservative.  It is commonly treated with 
nonsteroidal anti-inflammatory medications, physical therapy, and corticosteroid 
injections.  If conservative treatment fails, surgical option may be indicated1,3,7,11.    
Physical therapy interventions are considered an integral portion of treatment of 
PF. Many physical therapy regimens are available which may mitigate and relieve heel 
pain associated with PF.  In addition, rest and avoiding strenuous activities that place 
strain on the inflamed and irritated proximal insertion of plantar fascia may also allay 
inferior heel symptoms 9,10,40,41.   
In 2008, the orthopedic section of the American Physical Therapy Association 
(APTA) began issuing a series of evidence based clinical practice guidelines linked to the 
international classification of function, disability, and health which provide 
recommendations regarding  assessment, prognosis, diagnosis, and treatment for common 
musculoskeletal dysfunctions.  In terms of PF, many physical therapy interventions can 
be used to attenuate inferior heel symptoms associated with its presence,42.  These 
modalities include iontophoresis, manual therapy, night splinting, prefabricated and 
customized insets, shoe modification, stretching exercises of calf muscles and plantar 
fascia, taping, orthotic devices, which can be used to suit patient needs9-11,30,31,40-49.  Other 
physical therapy techniques may include soft tissue mobilization, heel padding, icing, 
contrast baths, ultrasound, and rest39,50,51.      
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Monophasic pulsed current (MPC) is utilized to promote wound and pressure 
ulcer healing processes. MPC is defined as percutaneous delivery of pulsed, twin-peak, 
monophasic pulses, each having very short phase duration of less than 100 μsec, which 
employs a voltage of up to 500 volts 52-54.  Delivery of electrical current using electrodes 
to the wound bed is presumed to induce cellular actions and histological responses such 
as collagen and deoxyribonucleic acid synthesis, adenosine triphosphate production, as 
well as increasing the number of growth factor receptors , and enhancing calcium influx 
52-59.  Vitro studies revealed that key tissue cells such epithelial and fibroblast cells have 
been attracted to wound site when electrically stimulated resulting in promoting collagen 
deposition, angiogenesis and wound tensile strength.  Many studies inferred that wounds 
treated with MPC demonstrated 1.5 times greater rate of healing when compared to 
normal wound healing rates 52-59.     
Galvanotaxis is one of the features of MPC and is defined as the process of 
attracting charged cells to an electric field of opposite polarity. In treating wounds or 
decubitus ulcers, a positively charged electrode (anode) is placed over a wound or ulcer, 
to attract negatively charged cells such as neutrophils and macrophages to facilitate the 
inflammatory phase of wound healing.  Plantar fascia is a connective tissue, and the 
fibroblast cells’ main function is to maintain its structural integrity. Fibroblasts are the 
key cells during the proliferation phase of fascia healing. Fibroblasts make the collagens, 
glycosaminoglycans, elastin fibers, and glycoproteins found in the extracellular 
matrix53,56,57,60.  Because polarity selection is based on the healing phase, we used the 
negatively charged cathode to attract the positively charged fibroblast cells to promote 
and accelerate proliferation phase of plantar fascia.  
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The primary focus of this study was to examine the effect of MPC and MPC 
coupled with plantar fascia stretching exercises on subjective reporting of heel pain, heel 
tenderness, and functional activities level on patients diagnosed with PF. 
We hypothesized that MPC would promote and precipitate the plantar fascia 
healing process thus mitigating inferior heel symptoms associated with PF.   
 
Materials and Methods 
Research Design 
This study is a prospective randomized clinical trial to compare the effectiveness 
of two interventions on the treatment of PF.  Participants were randomly assigned to one 
of two treatment groups.  Group I was treated with MPC and Group II was treated with a 
combination of MPC and plantar fascia SE. 
 
Participants 
This prospective randomized clinical trial was approved by the Institutional 
Review Board (IRB) at Loma Linda University (LLU) and conducted at the Physical 
Fitness Laboratory at the School of Allied Health Professions (SAHP), Department of 
Physical Therapy between March and September, 2013.  
The following inclusion/exclusion criteria were used to determine eligibility for 
enrollment in this clinical trial. Inclusion criteria included: (1) participants of both 
genders were diagnosed with PF; and (2) the diagnosis was made upon the finding of 
tenderness to pressure at the origin of plantar fascia on the medial tubercle of the 
calcaneus, as well as complaint of heel pain greater than or equal to 3 on a 1 to 10 VAS 
scale. Exclusion criteria included: (1) previous fracture or surgery to the foot; and (2) 
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specific metabolic and connective tissue disorders associated with or contributing to the 
diagnosis of PF (i.e., rheumatoid arthritis, gout, lupus).  
The recruitment of the participants was assisted by referrals from the Loma Linda 
Medical Center’s orthopedists, podiatrists, and primary care physicians (APPENDEX A). 
Additional recruitment was sourced via advertisements in Loma Linda Trading Post and 
online and weekly newspapers in area cities (APPENDEX B).  Also, study fliers were 
placed on bulletin boards of the Drayson Fitness Center of Loma Linda University as 
well as the School of Allied Health Professions (APPENDEX C), with electronic 
versions of the study flier having been sent to the School of Allied Health Professions 
students.  
If the referring physician felt patients would qualify for or benefit from 
participation in the clinical trial and ascertained patient interest, the patient was contacted 
with details about the study.  Participant permission was obtained by provision of 
Authorization for Use of Protected Health Information (PHI) (APPENDEX D). This form 
allowed the patient’s name, diagnosis, telephone number, date of birth, and gender to be 
forwarded to the study investigator (APPENDEX E).  The investigator contacted the 
patient by telephone to provide additional information regarding the study, address 
questions, and schedule a baseline evaluation session (APPENDEX F).    
A convenience sample of 48 patients with a clinical diagnosis of plantar fasciitis 
met this randomized clinical trial’s inclusion criteria and underwent the baseline 
evaluation. Four participants never retuned beyond the baseline evaluation session due to 
scheduling conflicts. Data analysis was based on the remaining 44 patients who provided 
written consent to continue with the study.  
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During the baseline evaluation, the investigator first explained the study to the 
patient, including its overall purpose, the procedures that would be performed, and 
potential benefits and risks of the interventions. If the patient decided to proceed, the 
investigator provided him/her a copy of the informed consent as approved by the IRB 
(APPENDEX G). If the patient chose to enroll in the study, he/she signed the consent 
form and California Experimental Subject’s Bill of Right Form (APPENDEX H). 
 
Procedure 
Following procurement of patient informed consent, the investigator obtained the 
patient’s demographic information (age, sex, height, weight, body mass index, duration 
of symptoms) as well as determining whether the patient was athletic or not, and on 
which side the affected area presented. A baseline evaluation was performed on the 
eligible participant and included the measurement of: (1) heel pain using the Visual 
Analogue Scale (VAS); (2) heel tenderness with pressure algometer (PA); and (3) 
functional activities level with Activities of Daily Living Subscale of the Foot and Ankle 
Ability Measure (ADL/ FAAM). 
The investigator then randomly assigned the participants to one of two treatment 
groups. Group I received MPC and Group II received MPC coupled with plantar fascia 
SE, using a computer-generated random two-digit number. Each patient received three 
sessions of MPC per week for four weeks, for a total of twelve sessions. Each session 
lasted 60 minutes. Patients in Group II were instructed to perform home based stretching 
exercises as described by Digiovanni8 (APPENDEX I). 
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The investigator instructed the patients on how to perform the plantar fascia SE 
and told them the number of daily sets to complete during the four week treatment. 
(APPENDEX J) 
  After completing the assigned treatments, the investigator performed a post-
intervention evaluation. The post-intervention evaluation included the measurement of: 
(1) heel pain using the VAS; (2) heel tenderness with PA; and (3) functional activities 
level using ADL/FAAM. 
 
Outcome Measures 
Visual Analogue Scale 
The visual analogue scale (VAS) was utilized to measure heel pain. VAS is a 
numerical scale with marked points at 0 and 10 while 0 indicates no pain, and10 indicates 
the highest level of pain (Figure 1). The patient was requested to rate his/her heel pain 
based on his/her initial steps in the morning, by putting a mark on the scale representing 
his/her level of heel pain. This scale has been established as a reliable and valid 
subjective outcome measure to assess acute and chronic pain61-63. 
 
 
 
Figure 1. Visual Analogue Scale (VAS) 
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Pressure Algometer 
A handheld pressure algometer (PA) was used to measure each patient’s heel 
tenderness threshold.  The threshold is defined as the minimum pressure force or pressure 
required to produce the sensation of pain. PA is a force gauge equipped with a rubber tip 
and calibrated in newton (WAGNER, compact digital Force Gauge) (Figure 2). To assess 
heel tenderness, the investigator directed the patient to recline in a supine position with 
affected leg fully extended. The investigator then palpated and marked the tender point 
over the origin of the plantar fascia at the medial tuberosity of calcareous. Finally, the 
investigator passively dorsiflexed the ankle and toes, applying the algometer over the 
marked placed on the medial tuberosity of the calcaneus.
  
The algometer contact head was 
aligned perpendicularly to the tender point with the investigator gradually increasing the 
algometer pressure until the patient reported pain.  The algometer reading, which 
represents the pressure needed to stimulate pain, was recorded in kilograms (Figure 3).  
Higher algometer scores indicated greater pressure tolerance and, hence, less tenderness.  
Lower algometer readings indicated less pressure tolerance and, thus, greater heel 
tenderness.
 
The reliability and validity of the pressure algometer as a subjective outcome 
measure of tenderness has been supported in the literature 64-66 . 
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Figure 2. Handheld Pressure Algometer (PA) 
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            Figure 3.  Heel Tenderness Measurement Technique 
 
Foot and Ankle Ability Measure 
To assess functional activity levels, the participants were asked to record their 
ability to perform daily activities using the Activities of Daily Living subscale of the Foot 
and Ankle Ability Measure (ADL/FAAM).  The ADL/FAAM identifies 21 daily 
activities, and participants rated their ability to complete each activity based on a scale 
ranging from no difficulty to inability to complete (APPENDEX K).  Individual 
participant responses to the ADL/FAAM questions were converted to numerical cores 
using a 5-point scale, with scale ranging from 0 “ no difficulty” to 4 “unable to do,” that 
particular daily activity.  A lower ADL/FAAM score indicated a higher functional 
activity level. ADL/FAAM is a self-reported instrument specific to those with lower leg 
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musculoskeletal disorders, known to be a reliable, valid, and responsive self-reported 
instrument for assessing the activity and function level for patients with lower leg 
musculoskeletal disorders67-69. 
 
Interventions 
Monophasic Pulsed Current 
MPC is utilized clinically to promote wound and pressure ulcer healing processes.  
MPC is defined as percutaneous delivery of pulsed, twin-peak, monophasic pulses, each 
pulse having very short phase duration of less than 100 μsec, which employs voltage up 
to 500 volts 52-54. Delivering of electrical current using electrodes to wound bed seems to 
induce cellular actions and histological responses such as collagen and deoxyribonucleic 
acid synthesis, adenosine triphosphate production, increase the number of growth factor 
receptor , and calcium influx, and. Vitro studies showed that key tissue cells such 
epithelial and fibroblast cells have been attracted to wound site when electrically 
stimulated resulting in promoting collagen deposition, angiogenesis and wound tensile 
strength. Many studies inferred that wounds treated with MPC demonstrated 1.5 times 
greater rate of healing when compared to normal wound healing rates52-59.      
Galvanotaxis is one of the MPC features and is defined as the process of attracting 
charged cells to an electric field of opposite polarity. Clinically in treating wounds or 
decubitus ulcers, a positively charged electrode (anode) is placed over a wound or ulcer, 
to attract negatively charged cells such as neutrophils and macrophages to facilitate the 
inflammatory phase of wound healing. Plantar fascia is a connective tissue, and the 
fibroblast cells’ main function is to maintain its structural integrity.  Fibroblasts are the 
key cells during the proliferation phase of fascia healing.  Fibroblasts make the collagens, 
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glycosaminoglycans, elastin fibers, and glycoproteins found in the extracellular 
matrix53,56,57,60.   
Because polarity selection is based on the healing phase the practitioner wishes to 
facilitate and accelerate, we used the negatively charged cathode to attract the positively 
charged fibroblast cells to promote and accelerate proliferation phase  plantar fascia 
healing process (GV 350 Galvanic High-Volt Pulsed Stimulator) (Figure 4, 5).  MPC has 
been shown to increase fibroblast proliferation and DNA and protein synthesis essential 
for the production of granulation tissue. The therapeutic parameters included:  current 
type (pulsed current), pulse type (twin peaked), electrode polarity cathode (negative), 
frequency (100 pulse per second), pulse duration (100 milliseconds), and mplitude (at 
submotor level, too weak to elicit a visible muscle contraction) 52-54.    
 
  
 Figure 4. GV 350 Galvanic High-Volt Pulsed Stimulator 
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   Figure 5. Monopolar Application of Monophasic Pulsed Current 
 
 
 
Plantar Fascia Stretching Exercise 
Plantar fascia stretching exercises (SE) are often considered an integral 
component of the physical therapy treatment plan for the treatment of PF, used to 
decrease pain and functional limitations.  In this study, plantar fascia specific SE were 
utilized as demonstrated by DiGiovanni  and his colleagues9.  The patient was directed to 
cross the affected leg over the other leg while in a sitting position, and using his/her hand, 
apply metatarso-phalangeal joint dorsiflexion (or pull the toes back toward the shin until 
the patient feels a stretch in the arch of the foot), while holding each stretch for a count of 
10, and repeating each stretch 10 times (Figure 6).  All patients were required to perform 
the SE program three times per day.  The first stretch was to be completed before rising 
29 
and exiting the bed. Patients were provided a written protocol of the stretching program 
and asked to keep a daily log of exercise completion for 4 weeks. (APPENDEX J) 
 
 
 Figure 6. Plantar Fascia Stretching Exercise 
 
Data Analysis 
Sample Size Estimation 
SAS statistical analysis software was used to calculate the sample size required so 
that a reasonable expectation would be likely to detect an expected effect size of 0.4 
between the two study groups.   A sample size of 40, with 20 participants per group with 
0% attrition rate was utilized in the study.  Forty participants were required to show 
statistical significance when clinically significant differences between the groups were 
present.  Additional participants were recruited to provide for unanticipated attrition.  
30 
Description of Statistical Procedures  
IBM SPSS Statistics Grad Pack 22.0 PREMIUM was used to analyze the data. 
Participants’ demographic data for each group was summarized using means and SDs for 
continuous variables and frequencies and percentages for categorical variables to 
determine if significant differences between the two the groups existed. The assumption 
of normality of the continuous variables was examined using the Kolmogorov- Smirnov 
test.  Also, the assumption of homogeneity was examined by Levene’s test. 
The two groups were compared at baseline using independent t-test. Differences 
were calculated between pre and post measurements for heel pain, heel tenderness, and 
functional activities level.  A mixed 2×2 factorial Analysis of Variance (ANOVA) was 
conducted to examine the effect of the two interventions monophasic pulsed current and 
combination of monophasic pulsed current and plantar fascia stretching exercises on heel 
pain, heel tenderness, and functional activities level.  To explore if changes in outcome 
measures over time were consistent across treatment groups, researchers examined 
whether there was an interaction between time and treatment group. The level of 
significance was set at P value ≤ 0.05. 
 
Results 
Of the 44 participants completing the study, 22 subjects were women, and 22 
were men (Figure 7).  The right foot was involved in 22 participants and the left foot in 
22. The mean age of Group I (received MPC) was 49.7 ± 11.7 years, and the mean age of 
Group II (received MPC couples with plantar fascia SE) was 49.0 ± 9.7 years. The mean 
height of Group I was 171.5 ± 12.0 cm and the mean height of Group II was 171.0 ± 13.5 
cm.  The mean weight of Group I was 96.4 ± 22.9 kg and the mean height of Group II 
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was 87.4 ± 22.9 kg.  The median duration of symptoms in Group I was 12 months with 
Interquartile Range (IQR) of 154, and for Group II was 12 months with IQR of 154, 
hence, the sample consisted primarily of participants with relatively chronic symptoms.  
All participants in the two treatment groups appeared to be generally well matched.  No 
significant differences between group I managed with MPC and group II managed with 
MPC coupled with plantar fascia SE were found in regards to age, gender, height, weight, 
body of mass index (BMI), athletic status, and affected side (Table 1).      
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   Figure 7. The Progression of Participants through the Clinical the Trial  
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Table 1. General Characteristics of Subjects (N= 44) 
 Group I  
(n=22) 
Group II 
(n=22) 
p-value 
Age, mean (SD) year 49.7(11.7) 49.0(9.7)  0.60 * 
Height, mean (SD) cm 171.5 (12.0) 171.0 (13.5) 0.91* 
Weight, mean (SD) kg 96.4 (22.9) 87.4 (22.9) 0.20* 
BMI, mean (SD) kg/m2 32.8 (7.2) 30.0 (7.4) 0.21* 
Standing hours, mean (SD)  8.8 (3.2) 9.6(2.48) 0.31* 
Duration of symptom,  
median (IQR) months 
12 (154) 12 (149) 0.12^ 
Gender 
Male, % (n) 36.4 (8) 31.8 (7) 0.75
# 
Female, % (n) 63.6 (14) 68.2 (15)  
Athletic 
status 
Athletic, % (n) 9.1  (2) 13.6 (3) 0.50
$ 
Non-Athletic, % (n) 90.9 (20) 86.4 (19)  
Involved 
side 
RT, % (n) 27.3 (6) 50.0 (11) 0.12
# 
LT, % (n) 72.7 (16) 50.0 (11)  
Abbreviations: SD, Standard deviation; BMI, Body mass index; IQR, Interquartile range; RT, Right; LT, Left 
*Independent t-test; ^ Mann Whitney U- test; # Pearson chi square; $Fisher's exact test 
 
 
 
Table 2. Mean (SD) of Outcome Measurements by Treatment Group at Baseline (N=44) 
 Group I 
(n=22) 
Group II 
(n=22) 
Difference p-value* 
VAS 7.39 (1.75) 6.84 (2.14) 0.55 0.36 
PA, N 17.41 (6.69) 14.47 (5.41) 2.94 0.12 
ADL/FAAM 34.14 (11.33) 30.64 (12.65) 3.50 0.34 
Abbreviations: SD, Standard deviation; VAS, Visual analog scale; PA, Pressure algometer; ADL, Activity 
of daily living; FAAM, Foot and ankle ability measure 
*Independent t-test 
 
 
 
Table 3.  Mean (SD) of Outcome Measures by Treatment Group over time (N = 44) 
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 Pre 
Mean(SD) 
Post 
Mean(SD) 
p-value* p-value# 
Pre-post 
by-group 
interaction 
VAS      
    Group I (n=22) 7.39 (1.75) 3.43 (1.95)  < 0.001 0.67 0.28 
  Group II (n=22) 6.84 (2.14) 3.55 (1.95)    
PA, N      
    Group I (n=22) 17.41 (6.69) 36.74 (9.11)  < 0.001 0.21 0.75 
 Group II (n=22)  14.47 (5.41) 34.55 (8.88)    
ADL/FAAM      
    Group I (n=22) 34.14 (11.33) 15.27 (12.31)  < 0.001 0.86 0.07 
 Group II (n=22) 30.64 (12.65) 17.55 (14.00)    
Abbreviations: SD, Standard deviation; VAS, Visual analog scale; PA, Pressure algometer; ADL, Activity 
of daily living; FAAM, Foot and ankle ability measure 
* Significant differences between pre- and post-intervention between two groups 
# Significant differences between two groups at post-intervention 
 
 
 
 
Table 4. Mean (SD) of Outcome Measurements by Treatment Group at Post Intervention 
(N = 44) 
 Group I 
(n=22) 
Group II 
(n=22) 
   Difference p-value* 
VAS        3.43 (1.95) 3.55 (1.95) - 0.11 0.85 
PA, kg/cm2 36.74 (9.11) 34.55 (8.88) 2.18 0.43 
ADL/FAAM 15.27 (12.31) 17.55 (14.00) -2.27 0.57 
Abbreviations: SD, Standard deviation; VAS, Visual analog scale; PA, Pressure algometer; ADL, Activity  
of daily  living; FAAM, Foot and ankle ability measure 
*Independent t-test 
 
 
At baseline evaluation, no significant differences existed between Group I and 
Group II with regard to VAS scores (p = 0.36, Table 2).  The two groups experienced 
improvement in heel pain after completing the assigned treatments compared with 
baseline VAS scores (p < 0.001), but differences between the two groups were small and 
statically insignificant (p = 0.85, Table 3; Figures 8,9).  
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The results of post intervention evaluation showed that Group I managed with 
MPC had reduction in heel pain by -3.96 scores (95% confidence interval (CI), −4.81 to -
3.10) compared to mean reduction of -3.30 scores  (95% CI, −4.19 to - 2.40) for   Group 
II managed with MPC coupled with plantar fascia SE. The mean difference for heel pain 
between the two groups was insignificant, mean reduction or difference of -.11; (95% CI, 
−1.30 to −1.07; Tables 3, 4). 
 
 
 
Figure 8.  Mean ± SD of Visual Analogue Scale Scores between the Two Groups over 
time 
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Figure 9.  Mean ± SD of Visual Analogue Scale Scores by Treatment Group over time.  
 
 
At baseline evaluation, no significant differences existed between Group I 
managed with MPC and Group II managed with MPC coupled with plantar fascia SE 
with regard to PA scores (p = 0.12, Table 2).  The two groups experienced improvement 
in heel tenderness after completing the assigned treatments compared with baseline PA 
cores (p < 0 .001), but no significant differences between the two groups were detected 
(p= 0.21, Table 3; Figure 10). 
Findings of post intervention evaluation showed that Group I managed with MPC 
had an improvement in heel tenderness of 19.33N (95% confidence interval (CI), 16.12 to 
22.53) compared to an improvement of  20.08 N (95% CI, 16.51 to 23.65)  for Group II 
managed with MPC coupled with plantar fascia SE. The mean difference for PA scores 
between the two groups was not significant, mean reduction or difference of 0.75 (95% 
CI, −5.4 to 3.90; Tables 3, 4). 
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Figure 10. Mean ± SD of Pressure Algometer scores between the Two Groups over time 
 
 
 
 
 
 
Figure 11. Mean ± SD of Pressure Algometer Scores by Treatment Group over time 
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At baseline, no significant differences existed between the two groups with regard 
to ADL/FAAM scores (p = 0.34, Table 2).  The two groups experienced improvements in 
functional activities of daily living after completing the assigned treatments compared 
with baseline ADL/FAAM scores (p < 0.001), but differences between the two groups 
were insignificant (p = 0.57, Table 3; Figures 12, 13). 
  Results of post intervention evaluation showed that Group I managed with MPC  
had an improvement in the ADL/FAAM of  -18.90 scores  (95% confidence interval (CI), 
−23.85 to -13.87) compared to  mean reduction of -13.09 scores (95% CI, −17.31to 
−8.85) for  Group II managed with MPC coupled with plantar fascia SE .The mean 
difference for ADL/FAAM scores  between the two groups was not significant, mean 
reduction or difference of -2.30 (95% CI, −10.29 to  5.74; Tables 3,4).   
 
 
 
Figure 12. Mean ± SD of Active Daily Living /Foot Ankle Ability Measure Scores 
between the Two Groups  
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Figure 13. Mean ± SD of Active Daily Living /Foot Ankle Ability Measure Scores by 
Treatment Group over time 
 
 
 
 
Discussion 
PF is the most common cause of heel pain. For the vast majority of conditions, 
most experience resolution of symptoms within 10 months3,7,19.   Disagreement exists 
regarding the etiology of PF.  Its causes are still debated among histologists, pathologists 
and different healthcare professionals7,11,31.   PF is presumed to be associated with 
overuse, training errors, improper or worn footwear, sudden increase in weight bearing 
activity, weak intrinsic foot muscles, and obesity8,10,11.  PF appears to result from an 
inflammatory reaction which occurs in conjunction with microtears within the plantar 
fascia9-11.  The majority of non-operative treatments for PF have demonstrated 
encouraging results9-11,30,31,40-49.       
Many physical therapy interventions can be used to alleviate inferior heel 
symptoms associated with plantar fasciitis30.  These modalities include iontophoresis, 
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manual therapy, night splinting, prefabricated and customized insets, shoe modification, 
stretching exercises of calf muscles and plantar fascia, taping, and orthotic 
devices10,30,31,40-42,44-46,48.  
MPC is utilized clinically to promote wound and pressure ulcer healing processes. 
It appears to induce cellular actions and histological responses such as collagen and 
deoxyribonucleic acid synthesis, adenosine triphosphate production, and increase the 
number of growth factor receptors, and aid in calcium influx52-59.    
The primary focus of this prospective clinical trial was to examine the effect of 
MPC and MPC coupled with plantar fascia SE on subjective reporting of heel pain, heel 
tenderness, and functional activities level on patients diagnosed with PF. To our 
knowledge no prior studies have been conducted to examine the effect of MPC on 
patients with PF.  
We hypothesized that the use of MPC would promote and accelerate healing 
processes, especially the proliferation phase associated with plantar fasciitis. Plantar 
fascia is a connective tissue, and the fibroblast cells’ main function is to maintain the 
structural integrity of connective tissue.  Fibroblasts make collagen, glycosaminoglycans, 
reticular and elastin fibers, and glycoproteins found in the extracellular matrix.  The 
promotion and acceleration of healing processes of the inflamed plantar fascia may 
decrease heel pain, tenderness, disability level, and thickness of plantar fascia imposed by 
PF.  We utilized plantar fascia SE in our study because such exercises are considered 
central to most conservative treatment plans for heel pain associated with PF. DiGiovanni 
reported a significant reduction in pain and improvement in the level of activities9. 
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The results of this prospective clinical trial are consistent with results of other 
clinical studies which have concluded that physical therapy interventions and the use of 
modalities may mitigate inferior heel and improve patients’ functional difficulties caused 
by plantar fasciitis10,30,31,40-42,44-46,48.                     
In this study, there were no significant differences between the two treatment 
groups in terms of age, sex height, weight, BMI, duration of heel symptoms, athletic 
status, and involved side. Participants’ characteristics in the two treatment groups 
appeared to be gwell matched and would not appear to affect the subjective outcome 
measures used to determine the effect of monophasic pulsed current on the treatment of 
plantar fasciitis. 
Findings from the  post intervention evaluation determined that both Group I 
managed with MPC and Group II managed with MPC coupled with plantar fascia SE 
experienced significant reduction in VAS scores  compared to baseline,  with a mean 
effect of -3.95 for Group I and -3.29 for  Group II.  The differences between the two 
groups were not significant.  The reduction in VAS scores in either group was clinically 
significant61-63. 
Comparison of the baseline pressure algometer scores revealed significant 
improvements in heel tenderness in both groups.  Group I managed with MPC and Group 
II managed with MPC coupled with plantar fascia SE displayed a mean effect of 19.33 N 
and 20.88 N on the PA scores, respectively. However, no significant difference existed 
between the two treatment groups. Improvement in the pressure algometer scores was 
large enough to be clinically important64-66. 
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This study showed significant improvement in the functional activities level for 
both groups.  Group I managed with MPC and Group II managed with MPC coupled with 
plantar fascia SE showed a mean effect of -18.9 and - 13.1 scores on the ADL/FAAM, 
respectively; however, no significant difference between the two treatment groups was 
revealed.  This reduction in ADL/FAAM scores was large enough to be clinically 
important67-69.   
The results of this prospective study are consistent with other physical therapy 
studies indicating that physical therapy interventions and modalities were efficient in 
improving inferior heel pain symptoms resulting from plantar fasciitis 10,30,31,40-42,44-46,48. 
The results of this trial need to be viewed in light of two limitations: First, the 
assessor was not blinded to treatment allocation and outcome assessment.  This is a 
potential source of bias.  Nevertheless, the outcome measures were subjective self-
reported by participant and ultrasound was used as an objective outcome measure.  
Second, more meticulous inclusion and exclusion criteria would be required to be able to 
make sound inferences about the effect of treatment.  For instance, the participants 
exhibited chronic symptoms with varying duration of symptoms.  Future research should 
target symptoms of a limited duration, i.e., less than 12 months. Third, because the 
sample of convenience was insufficiently large, we were unable to have the plantar fascia 
specific stretching exercise group reach a more reliable inference about the additive effect 
of the monophasic pulsed current effect. 
The strengths of this study were based on its prospective randomized design. 
Additionally, the attrition rate was not high. Finally, the number and duration of 
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treatments were based on clinical expertise and considered adequate to draw sound 
conclusions about the efficacy of the MPC.  
Based on this study’s findings, physical therapists are urged to use MPC as an 
effective treatment for patients clinically diagnosed with PF.  However, it is suggested 
that clinicians combine MPC with plantar fascia SE to promote and accelerate the healing 
process as well as regain and maintain the flexibility of the plantar fascia, even though 
this study did not support conclusively the additive effect of using plantar fascia SE on 
inferior heel symptoms associated with PF.  
Further studies are encouraged to address the limitations of this study, issues of 
plantar skin resistance on the treatment with MPC, and long-term effects of MPC on 
treatment of PF. 
 
Conclusion 
In conclusion, this prospective controlled trial supports the efficiency of MPC in 
reducing inferior heel pain and tenderness, and improving functional activities levels 
associated with PF.  MPC can be effective for treatment of patients with chronic PF and 
is considered a low risk and low cost alternative to costly and more invasive medical and 
surgical treatments.  This study yielded notable improvements in both groups in different 
subjective outcome measures. Further explanatory prospective controlled clinical trials 
are needed to draw more conclusive inferences about the efficacy and ability of MPC on 
patients with PF.  
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Abstract 
Background: Plantar fasciitis (PF) is one of the most common causes of heel and 
foot pain, affecting up to 2 million Americans each year. Monophasic pulsed current 
(MPC) is a method of electrical stimulation clinically used to promote and accelerate 
wound and decubitus ulcers healing processes. The aim of this prospective clinical trial 
was to investigate the effect of MPC and MPC coupled with plantar fascia specific 
stretching exercises (SE) on the plantar fascia sagittal thickness (ST) in patients with PF. 
Methods: Forty four participants (22 were women; 22 were men, with a mean age 
of 49 ± 10.6 years) diagnosed with plantar fasciitis were randomly allocated to receive 
MPC (n=22) or MPC coupled with plantar fascia SE (n=22).  All participants were 
clinically diagnosed with PF.  The ST of the proximal insertion of the plantar fascia was 
measured with musculoskeletal ultrasound (MSK US) using a linear array transducer. 
Results:  This study showed that the two treatment groups, Group I managed with 
MPC, and Group II received MPC coupled with plantar fascia SE, experienced a 
significant reduction in the sagittal thickness of the proximal insertion of plantar fascia, 
(P < 0.001). Although the differences between the two groups in the ST of plantar fascia 
were small and not statistically significant.  
Conclusion: This trial revealed the ability of MPC to reduce the ST of proximal 
plantar fascia caused by PF. Both MPC and MPC coupled with plantar fascia SE 
exhibited a similar reduction in the ST of plantar fascia. 
Keywords: plantar fasciitis, plantar fascia sagittal thickness, ultrasound, monophasic 
pulsed current, plantar fascia specific stretching exercises. 
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Introduction 
Plantar fasciitis (PF) was first described by William Wood in 1812 and he 
regarded its presentation to tuberculosis1-3.   PF as a clinical diagnosis is known by many 
pseudonyms:  jogger’s heel, heel spur syndrome, plantar fascial insertitis, calcaneal 
enthesopathy, subcalcaneal bursitis, subcalcaneal pain, stone bruise, calcaneal periostitis, 
neuritis and calcaneodynia4-6.   Proximal PF or plantar heel pain is the most common soft 
tissue disorder that causes inferior heel and rear foot pain in athletes as well as those not 
involved in sport activities7,8.  Proximal PF is a common clinical diagnostic entity usually 
affecting more than two million Americans every year. It constitutes approximately 15 % 
of foot dysfunction conditions in the United States, affects two million individuals, and 
accounts for more one million outpatient visits annually3,9,10.      
PF symptoms settle in 80% to 90% of conditions and resolution of symptoms 
occurs in majority of patients within ten months with conservative treatment2,7,11.   PF can 
be a painful, debilitating, and disabling condition that often frustrates not only the patient 
but also the physician because its etiology is still equivocal3,8,12,13.     
PF is considered to be an overuse syndrome and an inflammatory reaction from 
chronic irritation or microtears of proximal plantar fascia at its attachment at the medial 
tuberosity of the calcaneus2,14.  PF is defined as a localized inflammation of perifascial 
anatomical structures and plantar fascia at its proximal insertion on the medial tuberosity 
of the calcaneus resulting from chronic repetitive microtears and degeneration secondary 
to overuse, mechanical and congenital disorders3,7-10,15.     
PF is also clinically defined as inferior heel pain and tenderness of gradual onset, 
localized to the medial tuberosity of the calcaneus and exacerbated by weight bearing11,16.  
It can affect patients from childhood to older ages, but is most common in middle aged 
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women and young athletes. Inflammation of the plantar fascia is prevalent in joggers, 
long distance runners and tennis players as well as athletes, soccer players, gymnasts, 
volleyball and basketball players7,8,17.   PF is also common in overweight individuals with 
occupations that require extensive standing or weight bearing8,18,19.   
Plantar fascia or plantar aponeurosis is a thick and strong fibrous connective 
tissue which originates at the medial tuberosity of the calcaneus and fans out distally into 
three bands to attach into the bases of proximal phalanges or at the metatarsophalangeal 
joints to form the medial longitudinal arch of the foot11,18.   Plantar fascia lies superficial 
to the muscles of the plantar surface of the foot and divides into three portions: central or 
middle, lateral, and medial .The central or middle portion is considered to be the thickest 
component of the plantar fascia, and originates from the posterior aspect of the medial 
tuberosity of the calcaneus posterior to the origin of the flexor digitorum brevis tendon, 
and is its width is between 1.5 to 2.0 cm.  Distally, at the level of the metatarsophalangeal 
joints, the central portion of the plantar aponeurosis divides in to five bands, one for each 
of the toes3,20-24.     
 The lateral component of the plantar aponeurosis originates from the lateral aspect 
of the medial tuberosity of the calcaneus with its distal medial and lateral bands 
connecting to the plantar plate of the fourth toe and to the base of the fifth metatarsal 
bones respectively.  The medial component of the plantar aponeurosis is thin and lies 
superficial to the abductor hallucis muscle and connected medially with the dorsal fascia 
and laterally with the central component of the plantar aponeurosis3,18,20,21,23,25.            
Histological examination of biopsy samples  of the irritated  and inflamed plantar  
fascia reveal granulation tissue, fibroblast proliferation, and fibrosis , collagen necrosis, 
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chondroid metaplasia, and matrix calcification, all of which are suggestive of a repetitive 
strain and fascia degenerative process26,27.   
The windlass mechanism model is a term used to explain the responsibility of the 
plantar fascia dynamic function during a manner of walking28.  The plantar fascia 
functions through the windlass mechanism which was described first by Hicks as a 
mechanical model29,30.  The plantar fascia plays an important role in providing support for 
the foot through the stance phase of gait cycle.  During the toe off of the gait cycle, the 
extension of the toes at the metatarsophalangeal joints tightens the planter fascia and 
elevates the medial longitudinal arch thus forming a solid pivot of foot for push off30,31.   
The foot and its ligaments can be thought of as a truss or arch-like triangular structure, 
with the calcaneus, midtarsal joint, and metatarsals forming the medial longitudinal 
arch28,29.  
The etiology of PF remains unclear and is poorly understood and still debated 
among medical fraternity despite its high prevalence3,7,11.  Even the etiology of plantar 
fasciitis is poorly established in previous research literature, it is thought to be caused by 
intrinsic and extrinsic predisposing factors11,32.  Intrinsic precipitating factors that may 
make an individual vulnerable for the development of PF may include obesity and a body 
mass index of more than 30. Being overweight can increase stress upon plantar fascia 
during normal walking.  Secondly, advanced age can predispose an individual to PF.  
After the age of 40 years, the fat pad begins to degenerate, with loss of water content and 
collagen component that affects it elasticity. When sagittal the thickness of the fat pad 
decreases, it may result in minimizing shock absorbency of that anatomical structure and 
reduced protection of the calcaneal tuberosity and plantar fascia.  Thirdly, Achilles 
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tendon tightness and inadequate ankle dorsiflexion may lead to excessive subtalar 
pronation to compensate for that dysfunction and that over pronation contributes to 
plantar fascia elongation, overstretch and irritation.  Fourthly, excessive pronation (pes 
planus) is caused by plantar flexion and adduction of talus and can cause the height 
longitudinal arch of the foot to decrease and create strain on the plantar aponeurosis 
which can result in the development of PF 10,11,33.   Other intrinsic potential risk factors 
may include leg length discrepancy, excessive lateral tibial torsion, and excessive femoral 
anteversion, pes cavus and equinus, and sudden weight gain7,8,11 
Extrinsic potential predisposing factors that may make someone susceptible for 
the development of plantar fasciitis may include high intensity sport activities or training 
that require repetitive plantar flexion of the ankle joint and extension of the 
metatarsophalangeal joints and that mechanical overload and excessive tensile load that 
produce microtears within the plantar fascia, which eventually incites a chronic 
inflammatory response followed by degeneration8,33,34. Other extrinsic potential risk 
factors include the use of poor or worn footwear, occupational and recreational activities 
that require prolonged standing or weight bearing, and improper training techniques7,11,32.     
The classic feature and presentation of plantar fasciitis are mechanical symptoms 
of pain on the sole of the foot at the inferior region of the heel32,33.   The onset of the 
inferior heel pain is insidious and may worsen over time.  Pain may interfere with 
walking, particularly when taking the first few steps in the morning after getting out of 
the bed, or arising from a seat after prolonged sitting or inactivity.  The intense and 
shooting inferior heel pain can be so terrible that the patient may limp around with the 
affected heel off the ground.  By the end of the day, a dull aching pain typically happens 
56 
and may extend the midfoot and forefoot.  The sharp pain is usually localized to the 
plantarmedial aspect of the heel or over a small area near the proximal insertion of the 
plantar fascia at the medial tuberosity of the calcaneus3,18,19,26,32,33,35.   
The diagnosis of PF can be made through a thorough and comprehensive history 
taking and physical examination.  Heel pain, while taking first steps in the morning, is 
typical of PF and will reveal differences from other inferior heel pain dysfunctions. 
Inferior heel pain imposed by plantar fasciitis is not associated with paresthesia or 
nocturnal pain. Localized tenderness to palpation of plantar fascia at its origin on 
anteromedial aspect of the calcaneal tuberosity may be elicited by slight passive 
dorsiflexion movement of the toes or having the patient stands on the tips of the toes.  A 
windlass test is considered to be positive when passive dorsiflexion of the hallux 
reproduces pain and discomfort at the proximal plantar fascia. The evaluation of range of 
motion may reveal or demonstrate a restriction of ankle dorsiflexion by 5 degrees or more 
which indicates contracture of the Achilles tendon3,8,11,25,36.     
A plain radiograph does not support the diagnosis of plantar fasciitis but can be 
used to look for bony lesions of the foot.  Diagnostic ultrasonography is inexpensive and 
useful in ruling out soft tissue pathology of the heel.  Findings of diagnostic ultrasound 
that support the presence of plantar fasciitis include proximal plantar fascia thickness 
greater than 4 mm and areas of hypoechogenicity.  Magnetic resonance imaging, 
although expensive, is a valuable tool for assessing causes of recalcitrant heel 
pain11,18,21,37,38.  Diagnostic findings include increased proximal plantar fascia thickening 
with increased signal intensity on T2-weighted imaging11,18,26,39.  Differential diagnosis of 
plantar fasciitis includes calcaneal stress fractures, osteomyelitis, tumor, sacral 
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radiculopathy, Reiter's syndrome, Sever's disease, psoriatic arthritis, ankylosing 
spondylitis, tarsal tunnel syndrome, foreign body, and nerve entrapments7,8,11,34.     
The treatment of PF is primarily conservative. It is commonly treated with 
nonsteroidal anti-inflammatory medications, physical therapy, and corticosteroid 
injections. If conservative treatment fails, surgical option may be indicated1,3,7,11.     
Physical therapy plays a significant role in the treatment of plantar fasciitis32.  
Many physical therapy treatment options are available which may mitigate and allay the 
heel pain symptoms associated with PF.  Patient with PF is instructed to have rest and 
avoid any strenuous and arduous activities that place strain on the inflamed and irritated 
proximal insertion of plantar fascia9,10,40,41.  
In 2008, the orthopedic section of the American Physical Therapy Association 
began issuing a series of evidence based clinical practice guidelines linked to the 
international classification of function, disability, and health that provide 
recommendations about assessment, prognosis, diagnosis, and treatment for common 
musculoskeletal dysfunctions.  In terms of plantar fasciitis, there are many physical 
therapy interventions or means that can be used to alleviate and attenuate the inferior heel 
symptoms that are associated with plantar fasciitis32,42.  
These modalities include iontophoresis, manual therapy, night splinting, prefabricated 
and customized insets, shoe modification, stretching exercises of calf muscles and plantar 
fascia, taping, orthotic devices, which can be used to suit patient needs9-11,32,33,40-49.  Other 
physical therapy techniques may include soft tissue mobilization, heel padding, icing, 
contrast baths, ultrasound, and rest34,50,51.   
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MPC is utilized clinically to promote wound and pressure ulcers healing 
processes.  Delivering of electrical current using electrodes to wound bed appears to 
induce cellular actions and histological responses such as collagen and deoxyribonucleic 
acid synthesis, adenosine triphosphate production, increase the number of growth factor 
receptor, and calcium influx52-59.   Vitro studies showed that key tissue cells such 
epithelial and fibroblast cells have been attracted to wound site when electrically 
stimulated resulting in promoting collagen deposition, angiogenesis and wound tensile 
strength.  Many studies inferred that wounds treated with monophasic pulsed current 
demonstrated  1.5 times  greater rate of healing when compared to normal wound healing 
rates52-59.  MPC is defined as percutaneous delivery of pulsed, twin-peak, monophasic 
pulses, each pulse having very short phase duration of less than 100 μsec, which employs 
voltage up to 500 volts 52-54.  Galvanotaxis is one of the monophasic pulsed current 
features and  is defined as the process of attracting charged cells to an electric field of 
opposite polarity. Clinically in treating wounds or decubitus ulcers, a positively charged 
electrode (anode) is placed over a wound or pressure ulcer, to attract negatively charged 
cells such as neutrophils and macrophages to facilitate the inflammatory phase of wound 
healing.  Plantar fascia is a connective tissue, and the fibroblast cells’ main function is to 
maintain its structural integrity. Fibroblasts are the key cells during the proliferation 
phase of fascia healing. Fibroblasts make the collagens, glycosaminoglycans, elastin 
fibers, and glycoproteins found in the extracellular matrix53,56,57,60. Because polarity 
selection is based on the healing phase the practitioner wishes to facilitate and accelerate, 
we used the negatively charged cathode to attract the positively charged fibroblast cells to 
promote and accelerate proliferation phase of plantar fascia. 
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Musculoskeletal Ultrasound (MSK US) can be utilized as a diagnostic tool to 
corroborate or verify a clinical diagnosis of plantar fasciitis21,37,38.   Numerous diagnostic 
sonography studies showed that abnormal thickening of plantar fascia greater than 4 mm 
and reduced echogenicity are associated with plantar fasciitis23,25,36,49,61,62.  Many clinical 
trials have been conducted to measure the sagittal proximal thickness of the plantar fascia 
before and after a given treatment regimen to prove that treatment’s 
efficacy17,20,27,37,38,61,62.  
The primary focus of this study was to examine the effect of MPC and MPC 
coupled with plantar fascia SE on the ST of proximal plantar fascia on patients diagnosed 
with PF. 
 
Materials and Methods 
Research Design 
This study is a prospective randomized clinical trial to compare the effectiveness 
of two interventions on the treatment of plantar fasciitis. Participants were randomly 
assigned to one of two treatment groups.  Group I was treated with MPC and Group II 
was treated with a combination of MPC and plantar fascia SE. 
 
Participants 
This prospective randomized clinical trial was approved by the Institutional 
Review Board (IRB) at Loma Linda University and conducted at the Physical Fitness 
Laboratory at the School of Allied Health Professions, Department of Physical Therapy 
between March and September, 2013.  
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The following inclusion/exclusion criteria were used to determine eligibility of 
the participants for enrollment in this clinical trial. Inclusion criteria included: (1) 
subjects of both genders were diagnosed with plantar fasciitis; and (2) the diagnosis was 
made upon the finding of tenderness to pressure at the origin of plantar fascia on the 
medial tubercle of the calcaneus, as well as complaint of heel pain greater than or equal 
to 3 on a 1 to 10 VAS scale. Exclusion criteria included: (1) previous fracture or surgery 
to the foot; and (2) specific metabolic and connective tissue disorders associated with or 
contributing to the diagnosis of PF (i.e., rheumatoid arthritis, gout, lupus).  
The recruitment of the subjects was assisted by referrals from Loma Linda 
Medical Center’s orthopedists, podiatrists, and primary care physicians (APPENDEX A).  
Additional recruitment was sourced via advertisements in Loma Linda Trading Post and 
online and weekly newspapers in area cities (APPENDEX B).  Also, study fliers were 
placed on bulletin boards of the Draysen Fitness Center of Loma Linda University as well 
as the School of Allied Health Professions (APPENDEX C), with electronic versions of 
the study flier having been sent to the School of Allied Health Professions students.  
If the referring physician felt patients would qualify for or benefit from 
participation in the clinical trial and ascertained patient interest, the patient was contacted 
with details about the study.  Participant permission was obtained by provision of 
Authorization for Use of Protected Health Information (PHI) (APPENDEX D). This form 
allowed the patient’s name, diagnosis, telephone number, date of birth, and gender to be 
forwarded to the study investigator (APPENDEX E).  The investigator contacted the 
patient by telephone to provide additional information regarding the study, address 
questions, and schedule a baseline evaluation session (APPENDEX F).    
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A convenience sample of 48 patients with a clinical diagnosis of plantar fasciitis 
met this randomized clinical trial’s inclusion criteria and underwent the baseline 
evaluation.  Four subjects never retuned beyond the baseline evaluation session due to 
scheduling conflicts.  Data analysis was based on the remaining 44 patients who provided 
written consent to continue with the study.  
During the baseline evaluation, the investigator first explained the study to the 
patient, including its overall purpose, the procedures that would be performed, and 
potential benefits and risks of the interventions.  If the patient decided to proceed, the 
investigator provided him/her a copy of the informed consent as approved by the IRB 
(APPENDEX G).  If the patient chose to enroll in the study, he/she signed the consent 
form and California Experimental Subject’s Bill of Right Form (APPENDEX H). 
 
Procedure 
Following procurement of patient informed consent, the investigator obtained 
information regarding age, gender, height, weight, body mass index (BMI), duration of 
symptoms as well as determining  whether the patient was athletic or not, and on which 
side the affected area presented. A baseline evaluation was performed which included the 
measurement of ST of proximal plantar fascia with MSK US. 
The investigator then randomly assigned the participants to one of two treatment 
groups. Group I received MPC and Group II received MPC coupled with plantar fascia 
SE, using a computer-generated random two-digit number. Each patient received three 
sessions of MPC per week for four weeks, for a total of twelve sessions. Each session 
lasted 60 minutes. Patients in Group II were instructed to perform home based SE as 
described by Digiovanni and his colleagues9 (APPENDEX I). 
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The investigator instructed the patients on how to perform the plantar fascia SE 
and told them the number of daily sets to complete during the four week treatment. 
(APPENDEX J). After completing the assigned treatments, the investigator performed a 
post-intervention evaluation which included the measurement of ST of proximal plantar 
fascia with MSK US. 
 
Outcome Measures 
Musculoskeletal Ultrasound 
Musculoskeletal ultrasound (MSK US) is an imaging tool utilized for confirming 
a diagnosis of plantar fasciitis and differentiating its occurrence from other inferior heel 
pain conditions63. MSK US is a valid and valuable diagnostic tool which measures 
changes in plantar fascia thickness before and after a given treatment regimen to gauge 
the treatment’s efficacy. According to musculoskeletal ultrasound investigation, the 
standard normal or asymptomatic thickness value reported for the plantar fascia is 2.3 to 
4.0 mm36,54,62,64.  It is accepted that a thickness greater than 4 mm would be consistent 
with presentation of plantar fasciitis25,36.   Each involved foot was evaluated 
sonographically with an L14-6 MHz linear array transducer, using Mindray-M7 
Diagnostic Ultrasound System (Figure 14), and a coupling gel was applied to the plantar 
surface of the foot.  The plantar fascia is most effectively assessed with the patient in the 
prone position, with the affected foot hanging over the edge of the examination table and 
the ankle in neutral position.  The ultrasound transducer was placed vertically in relation 
to the plantar aspect of the heel.  Finally, the sagittal thickness of the proximal insertion 
of the plantar fascia was measured, at a reference point 5 mm from the proximal insertion 
at the anterior aspect of the inferior border of the calcaneus21,22,37,38,61,62,65 (Figure 15). 
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  Figure 14. Mindray-M7 Diagnostic Ultrasound System 
 
 
 
Figure 15. Measurements of the Sagittal Thickness of Plantar Fascia Technique 
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Interventions 
Monophasic Pulsed Current 
MPC is utilized clinically to promote wound and pressure ulcer healing processes. 
MPC is defined as percutaneous delivery of pulsed, twin-peak, monophasic pulses, each 
pulse having very short phase duration of less than 100 μsec, which employs voltage up 
to 500 volts 52-54.  Delivering of electrical current using electrodes to wound bed seems to 
induce cellular actions and histological responses such as collagen and deoxyribonucleic 
acid synthesis, adenosine triphosphate production, increase the number of growth factor 
receptor, and calcium influx52-59. Vitro studies showed that key tissue cells such epithelial 
and fibroblast cells have been attracted to wound site when electrically stimulated 
resulting in promoting collagen deposition, angiogenesis and wound tensile strength. 
Many studies inferred that wounds treated with MPC demonstrated 1.5 times greater rate 
of healing when compared to normal wound healing rates52-59.   
Galvanotaxis is one of the MPC features and is defined as the process of attracting 
charged cells to an electric field of opposite polarity.  Clinically in treating wounds or 
decubitus ulcers, a positively charged electrode (anode) is placed over a wound or ulcer, 
to attract negatively charged cells such as neutrophils and macrophages to facilitate the 
inflammatory phase of wound healing. Plantar fascia is a connective tissue, and the 
fibroblast cells’ main function is to maintain its structural integrity.  Fibroblasts are the 
key cells during the proliferation phase of fascia healing.  Fibroblasts make the collagens, 
glycosaminoglycans, elastin fibers, and glycoproteins found in the extracellular 
matrix53,56,57,60.  Because polarity selection is based on the healing phase the practitioner 
wishes to facilitate and accelerate, we used the negatively charged cathode to attract the 
positively charged fibroblast cells to promote and accelerate proliferation phase plantar 
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fascia healing process (GV 350 Galvanic High-Volt Pulsed Stimulator, Figure 4, 5).  
MPC has been shown to increase fibroblast proliferation and DNA and protein synthesis 
essential for the production of granulation tissue. The therapeutic parameters included:  
current type (pulsed current), pulse type (twin peaked), electrode polarity cathode 
(negative), frequency (100 pulse per second), pulse duration (100 milliseconds), and 
amplitude (at submotor level, too weak to elicit a visible muscle contraction) 52-54.  
 
 
 
 Figure 4.  GV 350 Galvanic High-Volt Pulsed Stimulator 
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Figure 5. Monopolar Application of Monophasic Pulsed Current 
 
 
 
Plantar Fascia Stretching Exercise 
Plantar fascia stretching exercises (SE) are an integral component of the physical 
therapy treatment plan for the treatment of PF, used to decrease pain and functional 
limitations. In this study,   plantar fascia SE was utilized as described by DiGiovanni  and 
his colleagues9.  The patient was directed to cross the affected leg over the other leg 
while in a sitting position, and using his/her hand, apply metatarso-phalangeal joint 
dorsiflexion (or pull the toes back toward the shin until the patient feels a stretch in the 
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arch of the foot), while holding each stretch for a count of 10, and repeating each stretch 
10 times (Figure 6).  All patients were required to perform the stretching program three 
times per day.  The first stretch was to be completed before rising and exiting the bed. 
Patients were provided a written protocol of the home based SE program and asked to 
keep a daily log of exercise completion for 4 weeks. (APPENDEX J) 
 
            
 
Figure 6. Plantar Fascia Stretching Exercise 
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Data Analysis 
Sample Size Estimation 
SAS statistical analysis software was used to calculate the sample size required so 
that a reasonable expectation would be likely to detect an expected effect size of 0.4 
between the two study groups.   A sample size of 40, with 20 participants per group with 
0% attrition rate was utilized in the study.  Forty participants were required to show 
statistical significance when clinically significant differences between the groups were 
present.  Additional participants were recruited to provide for unanticipated attrition.  
 
Description of Statistical Procedures  
IBM SPSS Statistics Grad Pack 22.0 PREMIUM was used to analyze the data. 
Participants’ demographic data for each group was summarized using descriptive 
statistics using means and SDs for continuous variables and frequencies and percentages 
for categorical variables to determine if significant differences between the two the 
groups existed. The assumption of normality of the continuous variables was examined 
using the Kolmogorov- Smirnov test.  Also, the assumption of homogeneity was 
examined by Levene’s test. 
The two groups were compared at baseline using independent t-test.  Differences 
were calculated between pre and post measurements for heel pain, heel tenderness, and 
functional activities level.  A mixed 2×2 factorial Analysis of Variance (ANOVA) was 
conducted to examine the effect of the two interventions MPC and combination of MPC 
and plantar fascia SE on heel pain, heel tenderness, and functional activities level. To 
explore if changes in outcome measures over time were consistent across treatment 
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groups, researchers examined whether there was an interaction between treatment group 
and time. The level of significance was set at P value ≤ 0.05.   
 
Results 
Of the 44 participants completing the study, 22 were women, and 22 were men 
(Figure 7). The right foot was involved in 22 participants and the left foot in 22. The 
mean age of Group I (received monophasic electrical stimulation) was 49.7 ± 11.7 years, 
and the mean age of Group II (received monophasic electrical stimulation couples with 
plantar fascia stretching exercises) was 49.0 ± 9.7 years. The mean height of Group I was 
171.5 ± 12.0 cm, and the mean height of Group II was 171.0 ± 13.5 cm. The mean weight 
of Group I was 96.4 ± 22.9 kg, and the mean height of Group II was 87.4 ± 22.9 kg.  The 
median duration of symptoms in Group I was 12 months with interquartile range (IQR) of 
154, and for Group II was 12 months with IQR of 154, hence, the sample consisted 
primarily of participants with relatively chronic symptoms.  All participants in the two 
treatment groups appeared to be generally well matched.  No significant differences 
between group I managed monophasic electrical stimulation and group II managed 
monophasic electrical stimulation coupled with plantar fascia stretching exercises were 
found in regards to height, weight, BMI age, gender, athletic status, and affected side 
(Table 1).     
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   Figure 7. The Progression of Participants through the Clinical the Trial  
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Table 1. General Characteristics of Subjects (N= 44) 
 Group I 
 (n=22) 
Group II 
(n=22) 
p-value 
Age, mean (SD) year 49.7 (11.7) 49.0 (9.7)  0.60 * 
Height, mean (SD) cm 171.5 (12.0) 171.0 (13.5) 0.91* 
Weight, mean (SD) kg 96.4 (22.9) 87.4 (22.9) 0.20* 
BMI, mean (SD) kg/m2 32.8 (7.2) 30.0 (7.4) 0.21* 
Standing hours, mean (SD)  8.8 (3.2) 9.6 (2.48) 0.31* 
Duration of symptom,  
median (IQR) months 
12 (154) 12 (149) 0.12^ 
Gender 
Male, % (n) 36.4 (8) 31.8 (7) 0.75
# 
Female, % (n) 63.6 (14) 68.2% (15)  
Athletic 
status 
Athletic, % (n) 9.1  (2) 13.6 (3) 0.50
$ 
Non-Athletic, % (n) 90.9 (20) 86.4 (19)  
Involved 
side 
RT, % (n) 27.3 (6) 50.0 (11) 0.12
# 
LT, % (n) 72.716) 50.0 (11)  
Abbreviations: SD, Standard deviation; BMI, Body mass index; IQR, Interquartile range; RT, Right; LT, Left 
*Independent t-test; ^ Mann Whitney U- test; # Pearson chi square; $Fisher's exact test 
 
 
 
Table 5. Mean (SD) of Sagittal Thickness of Plantar Fascia by Treatment Group at 
Baseline (N=44) 
 Group I Mean (SD) Group II Mean (SD) Difference p-value* 
ST (mm) 4.61 (1.19) 4.11 (0.99) 0.50 0.14 
Abbreviations: SD, Standard deviation; ST, Sagittal thickness. 
  *Independent t-test  
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Table 6. Mean (SD) of Sagittal Thickness of Plantar Fascia by Treatment Group over 
Time (N=44) 
 Pre 
Mean(SD) 
Post 
Mean(SD) 
p-value* p-value# 
Pre-post 
by-group 
interaction 
ST (mm)      
  Group I (n=22) 4.61 (1.19) 3.87 (1.19)   < 0.001 0.23 0.49 
  Group II (n=22) 4.11 (0.99) 3.45 (1.06)    
Abbreviations: SD, Standard deviation; ST, Sagittal thickness. 
* Significant differences between pre- and post-intervention between two groups 
# Significant differences between two groups at post-intervention 
 
 
 
Table 7. Mean (SD) of Sagittal Thickness by Treatment Group at Post Intervention 
(N=44) 
  
group I Mean (SD) 
group II Mean 
(SD) 
   Difference p-value* 
ST (mm) 3.87(1.19) 3.45 (1.06) 0.4 0.23 
Abbreviations: SD, Standard deviation; ST, Sagittal thickness. 
*Independent t-test 
 
 
 
At baseline evaluation, no significant differences existed between group I and 
group II with regard to MSK US measurement of the ST of proximal insertion of plantar 
fascia, (P = 0.14)  (Table 5, Figure 16).  The two groups experienced significant 
reduction in the ST of plantar fascia after completing the assigned treatments compared 
with baseline evaluation (p < 0.001), but differences between the two groups were small 
and statistically insignificant (P = 0.23) (Table 3, Figure 17).  
Post intervention evaluation showed that group I managed with MPC had a mean 
reduction of the proximal thickness of plantar fascia by -0.74 mm (95% confidence 
interval (CI), −0.93 to -0.55mm) compared to mean reduction of -0.66 mm (95% CI, 
−0.81 to −0.51 mm) for group II managed with MPC coupled with plantar fascia SE. 
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Figure 16. Mean ± SD of Sagittal Thickness by between the Two Groups 
 
 
 
 
 
Figure 17.  Mean ± SD of Sagittal Thickness by Treatment Group over time 
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Discussion  
The most common cause of inferior heel pain is plantar fasciits. Vast majority of 
the conditions experienced resolution of symptoms within 10 months 8,5,38.   It is related 
to overuse, training errors, improper or worn footwear, sudden increase in weight bearing 
activity, weak intrinsic foot muscles, and/or obesity8,10,11.  The majority of physical 
therapy interventions and modalities for PF have demonstrated positive and encouraging 
results9-11,32,40,41,43,44.  These interventions include iontophoresis, manual therapy, night 
splinting, prefabricated and customized insets, shoe modification, stretching exercises of 
calf muscles and plantar fascia, taping, and orthotic devices9-11,32,33,40-43,45-49. 
MPC is utilized clinically to promote wound and pressure ulcer healing processes. 
MPC seems to induce cellular and histological responses such as collagen and 
deoxyribonucleic acid synthesis, adenosine triphosphate production, increase the number 
of growth factor receptors, and enhance calcium influx52-59.   
Plantar fascia is a connective tissue, and the fibroblast cells’ main function is to 
maintain its structural integrity. Fibroblasts are the key cells during the proliferation 
phase of fascia healing. Fibroblasts create the collagens, glycosaminoglycans, elastin 
fibers, and glycoproteins found in the extracellular matrix53,56,57,60.  Negatively charged 
cathodes were used to attract positively charged fibroblast cells which promote and 
accelerate the proliferation phase of plantar fascia52-54.  
Plantar fascia stretching exercises were utilized in this study because they are 
considered central to most conservative treatment and viable therapeutic techniques for 
inferior heel pain associated with PF.  DiGiovanni et al reported that plantar fascia 
specific stretching exercises showed significant reduction in heel pain and improvement 
in the functional activities level in patients with PF9. 
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Musculoskeletal Ultrasound MSK US can be utilized as a diagnostic tool to 
corroborate or verify a clinical diagnosis of plantar fasciitis, although initially, it is not 
routinely required21,37,38.  It is often used to effectively evaluate plantar fascia pathology 
and rule out other heel dysfunctions.  Also, it can be useful as an objective outcome 
measure in evaluating the effectiveness of new or existing intervention for different 
musculoskeletal conditions22,63. 
   Many clinical trials have been conducted to measure the sagittal proximal 
thickness of the plantar fascia before and after a given treatment regimen to prove that 
treatment’s efficacy17,20,27,37,38,61,62.  Diagnostic sonography studies showed that abnormal 
thickening of plantar fascia greater than 4 mm and reduced echogenicity and loss of 
delineation of the borders of the plantar fascia distal to its proximal attachment on the 
medial tuberosity of the calcaneus of the fascia would be consistent with the presence of 
plantar fasciitis23,25,36,49,61,62.   
The primary focus of this study was to examine the effect of monophasic pulsed 
current and monophasic pulsed current coupled with plantar fascia-stretching exercises 
on abnormal change in sagittal thickness of proximal insertion of plantar fascia on 
patients diagnosed with plantar fasciitis. To our knowledge no prior studies have been 
conducted to examine the effect of monophasic pulsed current as a physical therapy 
modality on patients diagnosed clinically with plantar fasciitis using Musculoskeletal 
Sonography.  
 Each involved foot was evaluated sonographically with a L14-6 MHz linear array 
transducer (Mindray-M7 Diagnostic Ultrasound System) and acoustic coupling gel was 
applied to the plantar surface of the foot. All plantar fascia measurements were taken by 
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the investigator, who received individualized practical training sessions regarding using 
diagnostic ultrasound to measure the sagittal thickness of the proximal plantar fascia by 
two musculoskeletal radiology faculty and a chiropractor who is a registered diagnostic 
medical sonographer.  Each participant was examined while lying in a prone position 
with knee extended and ankle in the neutral position with the affected foot hanging over 
the edge of the examination table.  The ultrasound probe was applied vertically to the 
plantar aspect of the heel.  The sagittal thickness of the proximal insertion of the plantar 
fascia was measured to the nearest tenth of a millimeter at a reference point 5 mm from 
the proximal insertion at the anterior aspect of the inferior border of the calcaneus61,62. 
Data analysis of the of indicated there were no significant differences the 
participants’ characteristics between the two treatment groups in terms of age, gender, 
height, weight, BMI, duration of heel symptoms, athletic status, and involved side. 
Participants’ characteristics in the two treatment groups appeared to be generally well 
matched with each other and would not affect the objective outcome measure utilized to 
determine the effect of monophasic pulsed current on the treatment of plantar fasciitis. 
At baseline evaluation, no significant differences existed between Group I and 
Group II with regard to MSK US measurement of the ST of plantar fascia. 
The two groups experienced significant reduction in the ST of plantar fascia after 
completing the assigned treatments compared with baseline MSK US measurement but 
differences between the two groups were small and insignificant.  
After treatment, Group I managed MPC experienced a mean decrease in the 
sagittal thickness of plantar fascia by -0.74 mm (95% confidence interval (Cl), −0.93to -
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0.55 mm) compared to mean reduction of  -0.66 mm (95% CI, −0.80 to −0.51 mm) for 
Group II which managed with MPC coupled with plantar fascia SE. 
This study showed significant decrease in the sagittal thickness of proximal 
plantar fascia after the use of MPC. Findings of this clinical trial agreed with previous 
studies results about the efficacy of nonoperative treatment options in reducing abnormal 
proximal thickening of planter fascia caused by plantar fasciitis21-23,25,36,38,49,63.  
MSK US is a cost- and time-effective and useful imaging modality in ruling out 
soft tissue pathology of inferior heel dysfunction.  Based on the study’s findings, we 
recommend to use MSK US as an objective assessment tool in physical therapy 
outpatient settings to confirm a diagnosis of PF and to examine the efficiency of different 
physical therapy interventions and modalities.  Furthermore, physical therapists need to 
enroll in different levels of MSK US training courses and obtain professional certification 
in diagnostic sonography.  This professional skill will be crucial in exploring the 
effectiveness of current and novel physical therapy treatments.  
 
Conclusion 
MPC is an effective physical therapy intervention in decreasing the abnormal 
thickening of proximal planter fascia imposed by plantar fasciitis. MSK US is 
noninvasive, cost- and time-effective, and capable of confirming or excluding a diagnosis 
of plantar fasciitis.  It can be utilized in physical therapy practice in diagnosing and 
gauging the effectiveness of physical therapy interventions and modalities on the 
treatment of orthopedic conditions. 
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Abstract 
Background: Plantar fasciitis (PF) is one of the most common causes of foot 
complaints. The purpose of this prospective clinical trial was to investigate the 
correlation between the visual analogue scale (VAS) scores as a subjective outcome 
measure and Musculoskeletal Ultrasound (MSK US) as an objective measure when 
investigating the effect of monophasic pulsed current (MPC) and MPC coupled with 
plantar fascia stretching exercises (SE) on the treatment of PF. 
Methods: Forty four participants (22 were women; 22 were men, with a mean age 
of 49 ± 10.6    years) diagnosed with PF were randomly allocated to receive MPC (n=22) 
or MPC coupled with plantar fascia SE (n=22).  Prior to each treatment, participants 
underwent a baseline evaluation.  Heel pain was evaluated using the visual analogue scale 
(VAS) as subjective measure.  The sagittal thickness (ST) of the plantar fascia was 
measured with MSK US as an objective measure.  Following treatment, post intervention 
evaluation was performed using the same subjective and objective outcome measures. 
Results:  This study showed that the two groups experienced significant reduction 
in heel pain and in ST of the plantar fascia compared with baseline evaluation, (P <0.001) 
although the differences between the two groups in the reduction of heel pain and the 
sagittal thickness of plantar fascia were small and not statistically significant. The 
average reduction in heel pain did not correlate with the average reduction in the ST of 
the plantar fascia, (r = -.006, P = 0.97). 
Conclusion: This trial displayed the efficiency of MPC and MPC coupled with 
plantar fascia SE to reduce heel pain and sagittal thickness of the plantar fascia associated 
with PF, although no significant correlation existed between the average reduction in heel 
pain and ST of the plantar fascia.  
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Introduction 
Plantar fasciitis is (PF) is a common diagnostic entity and was first described by 
William Wood in 1812 and he attributed its presentation to tuberculosis1-3.   PF as a 
clinical diagnosis is known by many pseudonyms:  jogger’s heel, heel spur syndrome, 
plantar fascial insertitis, calcaneal enthesopathy, subcalcaneal bursitis, subcalcaneal pain, 
stone bruise, calcaneal periostitis, neuritis and calcaneodynia4-6.   Proximal PF or plantar 
heel pain is the most common soft tissue disorder that causes inferior heel and rear foot 
pain in athletes as well as those not involved in sport activities7,8.  Proximal PF is a 
common clinical diagnostic condition usually affecting more than two million Americans 
every year. It constitutes approximately 15 % of foot dysfunction conditions in the United 
States, affects two million individuals, and accounts for more one million outpatient visits 
annually3,9,10.      
PF is symptoms settle in 80% to 90% of conditions and the resolution of 
symptoms occurs in majority of patients within ten months with conservative 
treatment2,7,11.   PF can be a painful, debilitating, and disabling condition that often 
frustrates not only the patient but also the physician because its etiology is still 
equivocal3,8,12,13.     
PF is considered to be an overuse syndrome and an inflammatory reaction from 
chronic irritation or microtears of proximal plantar fascia at its attachment at the medial 
tuberosity of the calcaneus2,14.  PF is defined as a localized inflammation of perifascial 
anatomical structures and plantar fascia at its proximal insertion on the medial tuberosity 
of the calcaneus resulting from chronic repetitive microtears and degeneration secondary 
to overuse, mechanical and congenital disorders3,7-10,15.     
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PF is also clinically defined as inferior heel pain and tenderness of gradual onset, 
localized to the medial tuberosity of the calcaneus and exacerbated by weight bearing11,16.  
It can affect patients from childhood to older ages, but is most common in middle aged 
women and young athletes. Inflammation of the plantar fascia is prevalent in joggers, 
long distance runners and tennis players as well as soccer players, gymnasts, volleyball 
and basketball players7,8,17.   PF is also common   in overweight individuals with 
occupations that require extensive standing or weight bearing8,18,19.   
Plantar fascia or plantar aponeurosis is a thick and strong fibrous connective 
tissue which originates at the medial tuberosity of the calcaneus and fans out distally into 
three bands to attach into the bases of proximal phalanges or at the metatarsophalangeal 
joints to form the medial longitudinal arch of the foot11,18.   Plantar fascia lies superficial 
to the muscles of the plantar surface of the foot and divides into three portions: central or 
middle, lateral, and medial .The central or middle portion is considered to be the thickest 
component of the plantar fascia, and originates from the posterior aspect of the medial 
tuberosity of the calcaneus posterior to the origin of the flexor digitorum brevis tendon, 
and is its width is between 1.5 to 2.0 cm.  Distally, at the level of the metatarsophalangeal 
joints, the central portion of the plantar aponeurosis divides in to five bands, one for each 
of the toes3,20-24.     
 The lateral component of the plantar aponeurosis originates from the lateral aspect 
of the medial tuberosity of the calcaneus with its distal medial and lateral bands 
connecting to the plantar plate of the fourth toe and to the base of the fifth metatarsal 
bones respectively.  The medial component of the plantar aponeurosis is thin and lies 
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superficial to the abductor hallucis muscle and connected medially with the dorsal fascia 
and laterally with the central component of the plantar aponeurosis3,18,20,21,23,25.            
Histological examination of biopsy samples  of the irritated  and inflamed plantar  
fascia reveal granulation tissue, fibroblast proliferation, and fibrosis , collagen necrosis, 
chondroid metaplasia, and matrix calcification, all of which are suggestive of a repetitive 
strain and fascia degenerative process26,27.   
The windlass mechanism model is a term used to explain the responsibility of the 
plantar fascia dynamic function during a manner of walking28.  The plantar fascia 
functions through the windlass mechanism which was described first by Hicks as a 
mechanical model29,30.  The plantar fascia plays an important role in providing support for 
the foot through the stance phase of gait cycle.  During the toe off phase of the gait cycle, 
the extension of the toes at the metatarsophalangeal joints tightens the planter fascia and 
elevates the medial longitudinal arch thus forming a solid pivot of foot for push off 30,31.   
The foot and its ligaments can be thought of as a truss or arch-like triangular structure, 
with the calcaneus, midtarsal joint, and metatarsals forming the medial longitudinal 
arch28,29.  
The etiology of plantar fasciitis remains unclear and is poorly understood and is 
still debated among medical fraternity despite its high prevalence3,7,11.  Even the etiology 
of plantar fasciitis is poorly established in previous research literature, it is thought to be 
caused by intrinsic and extrinsic predisposing factors11,32.  Intrinsic precipitating factors 
that may make an individual vulnerable for the development of plantar fasciitis may 
include obesity and a body mass index of more than 30. Being overweight can increase 
stress upon plantar fascia during normal walking.  Secondly, advanced age can 
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predispose an individual to plantar fasciitis.  After the age of 40 years, the fat pad begins 
to degenerate, with loss of water content and collagen component that affects it elasticity. 
When the sagittal thickness of the fat pad decreases, it may result in minimizing shock 
absorbency of that anatomical structure and reduced protection of the calcaneal tuberosity 
and plantar fascia.  Thirdly, Achilles tendon tightness and inadequate ankle dorsiflexion 
may lead to excessive subtalar pronation to compensate for that dysfunction and that over 
pronation contributes to plantar fascia elongation, overstretch and irritation.  Fourthly, 
excessive pronation (pes planus) is caused by plantar flexion and adduction of talus and 
can cause the height longitudinal arch of the foot to decrease and create strain on the 
plantar aponeurosis which can result in the development of plantar fasciitis7,10,11,33.   
Other intrinsic potential risk factors may include leg length discrepancy, excessive lateral 
tibial torsion, and excessive femoral anteversion, pes cavus and equinus, and sudden 
weight gain7,8,11 
Potential extrinsic predisposing factors that may make someone susceptible for 
the development of plantar fasciitis may include high intensity sport activities or training 
that require repetitive plantar flexion of the ankle joint and extension of the 
metatarsophalangeal joints and that mechanical overload and excessive tensile load that 
produce microtears within the plantar fascia, which eventually incites a chronic 
inflammatory response followed by degeneration8,33,34. Other extrinsic potential risk 
factors include the use of poor or worn footwear, occupational and recreational activities 
that require prolonged standing or weight bearing, and improper training techniques7,11,32.     
The classic feature and presentation of plantar fasciitis are mechanical symptoms 
of pain on the sole of the foot at the inferior region of the heel32,33.   The onset of the 
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inferior heel pain is insidious and may worsen over time.  Pain may interfere with 
walking, particularly when taking the first few steps in the morning after getting out of 
the bed, or arising from a seat after prolonged sitting or inactivity.  The intense and 
shooting inferior heel pain can be so terrible that the patient may limp around with the 
affected heel off the ground.  By the end of the day, a dull aching pain typically happens 
and may extend the midfoot and forefoot.  The sharp pain is usually localized to the 
plantarmedial aspect of the heel or over a small area near the proximal insertion of the 
plantar fascia at the medial tuberosity of the calcaneus3,18,19,26,32,33,35.   
The diagnosis of plantar fasciitis can be made through a thorough and 
comprehensive history taking and physical examinations.  Heel pain, while taking first 
steps in the morning, is typical of plantar fasciitis and will reveal differences from other 
inferior heel pain dysfunctions. Inferior heel pain imposed by plantar fasciitis is not 
associated with paresthesia or nocturnal pain. Localized tenderness to palpation of plantar 
fascia at its origin on anteromedial aspect of the calcaneal tuberosity may be elicited by 
slight passive dorsiflexion of the toes or having the patient stands on the tips of the toes.  
A windlass test is considered to be positive when passive dorsiflexion of the hallux 
reproduces pain and discomfort at the proximal plantar fascia. The evaluation of range of 
motion may reveal or demonstrate a restriction of ankle dorsiflexion by 5 degrees or more 
which indicates contracture of the Achilles tendon3,8,11,25,36.     
A plain radiograph does not support the diagnosis of plantar fasciitis but can be 
used to look for bony lesions of the foot.  Diagnostic ultrasonography is inexpensive and 
useful in ruling out soft tissue pathology of the heel.  Findings of diagnostic ultrasound 
that support the presence of plantar fasciitis include proximal plantar fascia thickness 
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greater than 4 mm and areas of hypoechogenicity.  Magnetic resonance imaging, 
although expensive, is a valuable tool for assessing causes of recalcitrant heel 
pain11,18,21,37,38.  Diagnostic findings include increased proximal plantar fascia thickening 
with increased signal intensity on T2-weighted imaging11,18,26,39.  Differential diagnosis of 
plantar fasciitis includes calcaneal stress fractures, osteomyelitis, tumor, sacral 
radiculopathy, Reiter's syndrome, Sever's disease, psoriatic arthritis, ankylosing 
spondylitis, tarsal tunnel syndrome, foreign body, and nerve entrapments7,8,11,34.     
The treatment of plantar fasciitis is primarily conservative. It is commonly treated 
with nonsteroidal anti-inflammatory medications, physical therapy, and corticosteroid 
injections. If conservative treatment fails, surgical option may be indicated1,3,7,11.     
Physical therapy plays a significant role in the treatment of plantar fasciitis32.  
Many physical therapy treatment options are available which may mitigate and allay the 
heel pain symptoms associated with plantar fasciitis besides rest and avoiding any 
strenuous and arduous activities that place strain on the inflamed and irritated proximal 
insertion of plantar fascia9,10,40,41.  
In 2008, the orthopedic section of the American Physical Therapy Association 
began issuing a series of evidence based clinical practice guidelines linked to the 
international classification of function, disability, and health that gives recommendations 
about assessment, prognosis, diagnosis, and treatment for common musculoskeletal 
dysfunctions.  In terms of plantar fasciitis, there are many physical therapy interventions 
or means that can be used to alleviate and attenuate the inferior heel symptoms that are 
associated with plantar fasciitis32,42.  
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These modalities include iontophoresis, manual therapy, night splinting, prefabricated 
and customized insets, shoe modification, stretching exercises of calf muscles and plantar 
fascia, taping, orthotic devices, which can be used to suit patient needs9-11,32,33,40-49.  Other 
physical therapy techniques may include soft tissue mobilization, heel padding, icing, 
contrast baths, ultrasound, and rest34,50,51.   
Monophasic pulsed current (MPC) is utilized clinically to promote wound and 
pressure ulcer healing processes.  Monophasic pulsed current is defined as percutaneous 
delivery of pulsed, twin-peak, monophasic pulses, each pulse having very short phase 
duration of less than 100 μsec, which employs voltage up to 500 volts 52-54.  Delivering of 
electrical current using electrodes to wound bed seems to induce cellular actions and 
histological responses such as collagen and deoxyribonucleic acid synthesis, adenosine 
triphosphate production, increase the number of growth factor receptor, and calcium 
influx 52-59.Vitro studies showed that key tissue cells such epithelial and fibroblast cells 
have been attracted to wound site when electrically stimulated resulting in promoting 
collagen deposition, angiogenesis and wound tensile strength.  Many studies inferred that 
wounds treated with monophasic pulsed current demonstrated  1.5 times  greater rate of 
healing when compared to normal wound healing rates52-59.  Galvanotaxis is one of the 
MPC features and is defined as the process of attracting charged cells to an electric field 
of opposite polarity. Clinically in treating wounds or decubitus ulcers, a positively 
charged electrode (anode) is placed over a wound or ulcer, to attract negatively charged 
cells such as neutrophils and macrophages to facilitate the inflammatory phase of wound 
healing.  Plantar fascia is a connective tissue, and the fibroblast cells’ main function is to 
maintain its structural integrity. Fibroblasts are the key cells during the proliferation 
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phase of fascia healing. Fibroblasts make the collagens, glycosaminoglycans, elastin 
fibers, and glycoproteins found in the extracellular matrix53,56,57,60.  Because polarity 
selection is based on the healing phase the practitioner wishes to facilitate and accelerate, 
we used the negatively charged cathode to attract the positively charged fibroblast cells to 
promote and accelerate proliferation phase of plantar fascia. 
Musculoskeletal Ultrasound MSK US can be utilized as a diagnostic tool to 
corroborate or verify a clinical diagnosis of plantar fasciitis21,37,38.   Numerous diagnostic 
sonography studies showed that abnormal thickening of plantar fascia greater than 4 mm 
and reduced echogenicity are associated with plantar fasciitis23,25,36,49,61,62.  Many clinical 
trials have been conducted to measure the sagittal proximal thickness of the plantar fascia 
before and after a given treatment regimen to prove that treatment’s 
efficacy17,20,27,37,38,61,62.  
In previous physical therapy studies, the effect of the interventions and modalities 
on the treatment of plantar fasciitis was investigated mainly using subjective self- 
reported outcome measures.  Even the psychometric or clinimetric properties of those 
outcomes measured have been documented in the literature63-65,67-72.   It is important to 
employ reliable, valid and responsive subjective outcome measures such as ultrasound in 
physical therapy research on examining the capacity of physical therapy 
treatments21,22,37,38,61,62. 
The purpose of this prospective clinical trial was to investigate the correlation 
between the change of heel pain scores using visual analogue scale VAS as a subjective 
outcome measure and the change in the sagittal thickness of plantar fascia using 
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musculoskeletal ultrasound MSK US as an objective measure when investigating the 
effect of MPC and MPC coupled with plantar fascia specific SE in the treatment of PF. 
 
\Materials and Methods 
Research Design 
This study is a prospective randomized clinical trial to compare the effectiveness 
of two interventions on the treatment of plantar fasciitis. Participants were randomly 
assigned to one of two treatment groups. Group I was treated with MPC and Group II 
was treated with a combination of MPC and plantar fascia SE. 
 
Participants 
This prospective randomized clinical trial was approved by the Institutional 
Review Board (IRB) at Loma Linda University and conducted at the Physical Fitness 
Laboratory at the School of Allied Health Professions, Department of Physical Therapy 
between March and September, 2013. The following inclusion/exclusion criteria were 
used to determine eligibility of the participants for enrollment in this clinical trial. 
Inclusion criteria included: (1) participants of both genders were diagnosed with plantar 
fasciitis; and (2) the diagnosis was made upon the finding of tenderness to pressure at the 
origin of plantar fascia on the medial tubercle of the calcaneus, as well as complaint of 
heel pain greater than or equal to 3 on a 1 to 10 VAS scale. Exclusion criteria included: 
(1) previous fracture or surgery to the foot; and (2) specific metabolic and connective 
tissue disorders associated with or contributing to the diagnosis of PF (i.e., rheumatoid 
arthritis, gout, lupus).  
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The recruitment of the participants was assisted by referrals from the Loma Linda 
Medical Center’s orthopedists, podiatrists, and primary care physicians (APPENDEX A). 
Additional recruitment was sourced via advertisements in Loma Linda Trading Post and 
online and weekly newspapers in area cities (APPENDEX B). Finally, study fliers were 
placed on bulletin boards of the Draysen Fitness Center of Loma Linda University as well 
as the School of Allied Health Professions (APPENDEX C), with electronic versions of 
the study flier having been sent to the School of Allied Health Professions students.  
If the referring physician felt patients would qualify for or benefit from 
participation in the clinical trial and ascertained patient interest, the patient was contacted 
with details about the study.  Participant permission was obtained by provision of 
Authorization for Use of Protected Health Information (PHI) (APPENDEX D) for the 
patient to read and sign. This form allowed the patient’s name, diagnosis, phone number, 
date of birth, and gender to be forwarded to the study investigator (APPENDEX E).  The 
investigator contacted the patient by telephone to provide additional information 
regarding the study, address questions, and schedule a baseline evaluation session 
(APPENDEX F).    
A convenience sample of forty-eight patients with a clinical diagnosis of plantar 
fasciitis met this randomized clinical trial’s inclusion criteria and underwent the baseline 
evaluation.  Four subjects never retuned beyond the baseline evaluation session due to 
scheduling conflicts. Data analysis was based on the remaining 44 patients and who 
provided written consent to continue with the study.  
During the baseline evaluation, the investigator first explained the study to the 
patient, including its overall purpose, the procedures that would be performed, and 
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potential benefits and risks of the interventions. If the patient decided to proceed, the 
investigator provided him/her a copy of the informed consent as approved by the IRB 
(APPENDEX G).  If the patient chose to enroll in the study, he/she signed the consent 
form and California Experimental Subject’s Bill of Right Form (APPENDEX H). 
 
Procedure 
Following procurement of patient informed consent, the investigator obtained 
information regarding age, gender, height, weight, body mass index (BMI), duration of 
symptoms as well as determining whether the patient was athletic or not, and on which 
side the affected area presented. A baseline evaluation was performed which included the 
measurement of: (1) heel pain using the Visual Analogue Scale (VAS); (2) the 
measurement of sagittal thickness of proximal plantar fascia with Musculoskeletal 
Ultrasound MSK US. 
The investigator then randomly assigned the participants to one of two treatment 
groups. Group I received MPC and Group II received MPC coupled with plantar fascia 
SE, using a computer-generated random two-digit number. Each patient received three 
sessions of MPC per week for four weeks, for a total of twelve sessions. Each session 
lasted 60 minutes. Patients in Group II were instructed to perform home based SE as 
described by DiGiovanni et al 9 (APPENDEX I). 
The investigator instructed the patients on how to perform the plantar fascia SE 
and told them the number of daily sets to complete during the four week treatment. 
(APPENDEX J) 
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 After completing the assigned treatments, the investigator performed a post-
intervention evaluation which included the measurement of: (1) heel pain using the 
VAS); (2) the measurement of ST of proximal plantar fascia with MSK US. 
 
Outcome Measures 
Visual Analogue Scale 
The visual analogue scale (VAS) was utilized to measure heel pain. VAS is a 
numerical scale with marked points at 0 and 10, while 0 indicating no pain, and 10 
indicating the highest level of pain. (Figure1).  The patient was requested to rate his/her 
heel pain based on his/her initial steps in the morning, by putting a mark on the scale 
representing his/her level of heel pain. This scale has been established as a reliable and 
valid subjective outcome measure to assess acute and chronic pain63-65.  
 
 
 
Figure 1. Visual Analogue Scale (VAS) 
 
Musculoskeletal Ultrasound 
Musculoskeletal ultrasound (MSK US) is an imaging tool utilized for confirming 
a diagnosis of plantar fasciitis and differentiating its occurrence from other inferior heel 
pain conditions66. MSK US is a valid and valuable diagnostic tool which measures 
changes in plantar fascia thickness before and after a given treatment regimen to gauge 
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the treatment’s efficacy. According to musculoskeletal ultrasound investigation, the 
standard normal or asymptomatic thickness value reported for the plantar fascia is 2.3 to 
4.0 mm23,36,61,62.   It is accepted that a thickness greater than 4 mm would be consistent 
with presentation of plantar fasciitis25,36.    Each involved foot was evaluated 
sonographically with an L14-6 MHz linear array transducer, using Mindray-M7 
Diagnostic Ultrasound System (Figure 14), and a coupling gel was applied to the plantar 
surface of the foot.  The plantar fascia is most effectively assessed with the patient in the 
prone position, with the affected foot hanging over the edge of the examination table and 
the ankle in neutral position.  The ultrasound probe was placed vertically in relation to the 
plantar aspect of the heel.  Finally, the sagittal thickness of the proximal insertion of the 
plantar fascia was measured, at a standard reference point 5 mm from the proximal 
insertion at the anterior aspect of the inferior border of the calcaneus21,22,37,38,61,62 (Figure 
15). 
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 Figure 14. Mindray-M7 Diagnostic Ultrasound System 
 
 
Figure 15. Measurements of the Sagittal Thickness of Plantar Fascia Technique 
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Interventions 
Monophasic Pulsed Current (MPC) 
MPC is utilized clinically to promote wound and pressure ulcers healing 
processes. MPC is defined as percutaneous delivery of pulsed, twin-peak, monophasic 
pulses, each pulse having very short phase duration of less than 100 μsec, which employs 
voltage up to 500 volts 52-54. 
Delivering of electrical current using electrodes to wound bed seems to induce 
cellular actions and histological responses such as collagen and deoxyribonucleic acid 
synthesis, adenosine triphosphate production, increase the number of growth factor 
receptor, and calcium influx52-59. Vitro studies showed that key tissue cells such epithelial 
and fibroblast cells have been attracted to wound site when electrically stimulated 
resulting in promoting collagen deposition, angiogenesis and wound tensile strength. 
Many studies inferred that wounds treated with monophasic pulsed current demonstrated  
1.5 times  greater rate of healing when compared to normal wound healing rates52-59.   
Galvanotaxis is one of the MPC features and is defined as the process of attracting 
charged cells to an electric field of opposite polarity.  Clinically in treating wounds or 
decubitus ulcers, a positively charged electrode (anode) is placed over a wound or ulcer, 
to attract negatively charged cells such as neutrophils and macrophages to facilitate the 
inflammatory phase of wound healing. Plantar fascia is a connective tissue, and the 
fibroblast cells’ main function is to maintain its structural integrity.  Fibroblasts are the 
key cells during the proliferation phase of fascia healing.  Fibroblasts make the collagens, 
glycosaminoglycans, elastin fibers, and glycoproteins found in the extracellular 
matrix53,56,57,60.  Because polarity selection is based on the healing phase the practitioner 
wishes to facilitate and accelerate, we used the negatively charged cathode to attract the 
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positively charged fibroblast cells to promote and accelerate proliferation phase plantar 
fascia healing process (GV 350 Galvanic High-Volt Pulsed Stimulator, Figures 4, 5).   
MPC has been shown to increase fibroblast proliferation and DNA and protein 
synthesis essential for the production of granulation tissue. The therapeutic parameters 
included:  current type (pulsed current), pulse type (twin peaked), electrode polarity 
cathode (negative), frequency (100 pulse per second), pulse duration (100 milliseconds), 
and amplitude (at submotor level, too weak to elicit a visible muscle contraction) 53,54,57.   
 
 
 
 Figure 4. GV 350 Galvanic High-Volt Pulsed Stimulator 
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Figure 5. Monopolar Application of Monophasic Pulsed Current 
 
Plantar Fascia Stretching Exercise 
Plantar fascia stretching exercises (SE) are an integral component of the physical 
therapy treatment plan for the treatment of plantar fasciitis, used to decrease pain and 
functional limitations. In this study,   plantar fascia specific stretching exercises were 
utilized as described by DiGiovanni  and his colleagues9.  The patient was directed to 
cross the affected leg over the other leg while in a sitting position, and using his/her hand, 
apply metatarso-phalangeal joint dorsiflexion (or pull the toes back toward the shin until 
the patient feels a stretch in the arch of the foot), while holding each stretch for a count of 
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10, and repeating each stretch 10 times (Figure 6).  All patients were required to perform 
the stretching program three times per day.  The first stretch was to be completed before 
rising and exiting the bed. Patients were provided a written protocol of the stretching 
program and asked to keep a daily log of exercise completion for 4 weeks. (APPENDEX 
J) 
 
 
 
 Figure 6. Plantar Fascia Stretching Exercise 
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Data Analysis 
Sample Size Estimation 
SAS statistical analysis software was used to calculate the sample size required so 
that a reasonable expectation would be likely to detect an expected effect size of 0.4 
between the two study groups.   A sample size of 40, with 20 participants per group with 
0% attrition rate was utilized in the study. Forty participants were required to show 
statistical significance when clinically significant differences between the groups were 
present. Additional participants were recruited to provide for unanticipated attrition.  
 
Description of Statistical Procedures  
IBM SPSS Statistics Grad Pack 22.0 PREMIUM was used to analyze the data. 
Participants’ demographic data for each group was summarized using descriptive 
statistics using means and SDs for continuous variables and frequencies and percentages 
for categorical variables to determine if significant differences between the two the 
groups existed. The assumption of normality of the continuous variables was examined 
using the Kolmogorov- Smirnov test.  Also, the assumption of homogeneity was 
examined by Levene’s test. 
The two groups were compared at baseline using independent t-test. Differences 
were calculated between pre and post measurements for heel pain, heel tenderness, and 
functional activities level. A mixed 2×2 factorial Analysis of Variance (ANOVA) was 
conducted to examine the effect of the two interventions monophasic pulsed current and 
combination of monophasic pulsed current and plantar fascia stretching exercises on heel 
pain, heel tenderness, and functional activities level. To explore if changes in outcome 
measures over time were consistent across treatment groups, researchers examined 
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whether there was an interaction in between treatment group and time. The level of 
significance was set at P value ≤ 0.05. 
 
Results 
Of the 44 participants completing the study, 22 were women, and 22 were men 
(Figure 7). The right foot was involved in 22 participants and the left foot in 22.  The 
mean age of Group I (received monophasic electrical stimulation) was 49.7 ± 11.7 years, 
and the mean age of Group II (received monophasic electrical stimulation couples with 
plantar fascia stretching exercises) was 49.0 ± 9.7 years.  The mean height of Group I 
was 171.5 ± 12.0 cm, and the mean height of Group II was 170.98 ± 13.54cm.  The mean 
weight of Group I was 96.4 ± 22.9 kg, and the mean height of Group II was 87.4 ± 22.9 
kg.  The median duration of symptoms in Group I was 12 months with interquartile range 
(IQR) of 154, and for Group II was 12 months with IQR of 154, hence, the sample 
consisted primarily of participants with relatively chronic symptoms.  All participants in 
the two treatment groups appeared to be generally well matched.  No significant 
differences between group I managed monophasic electrical stimulation and group II 
managed monophasic electrical stimulation coupled with plantar fascia stretching 
exercises were found in regards to age, gender, height, weight, body mass index  (BMI), 
athletic status and involved side (Table 1).      
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Figure 7. The Progression of Participants through the Clinical the Trial  
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Table 1. General Characteristics of Subjects (N= 44) 
 Group I 
 (n=22) 
Group II 
(n=22) 
p-value 
Age, mean (SD) year 49.7 (11.7) 49.0 (9.7)  0.60 * 
Height, mean (SD) cm 171.5 (12.0) 171.0 (13.5) 0.91* 
Weight, mean (SD) kg 96.4 (22.9) 87.4 (22.9) 0.20* 
BMI, mean (SD) kg/m2 32.8 (7.2) 30.0 (7.4) 0.21* 
Standing hours, mean (SD)  8.8 (3.2) 9.6 (2.48) 0.31* 
Duration of symptom,  
median (IQR) months 
12 (154) 12 (149) 0.12^ 
Gender 
Male, % (n) 36.4 (8) 31.8 (7) 0.75
# 
Female, % (n) 63.6 (14) 68.2 (15)  
Athletic 
status 
Athletic, % (n) 9.1  (2) 13.6 (3) 0.50
$ 
Non-Athletic, % (n) 90.9 (20) 86.4 (19)  
Involved 
side 
RT, % (n) 27.3 (6) 50.0 (11) 0.12
# 
LT, % (n) 72.7 (16) 50.0 (11)  
Abbreviations: SD, Standard deviation; BMI, Body mass index; IQR, Interquartile range; RT, Right; LT, Left 
*Independent t-test; ^ Mann Whitney U- test; # Pearson chi square; $Fisher's exact test 
 
 
 
Table 8. Mean (SD) of Visual Analogue Scale and Sagittal Thickness by Treatment 
Group at baseline (N=44) 
 group I Mean (SD) group II Mean (SD) Difference p-value* 
VAS 7.39 (1.75) 6.84 (2.14) 0.55 0.36 
ST 4.61 (1.19) 4.11 (0.99) 0.50 0.14 
Abbreviations: SD, Standard deviation; VAS, Visual Analogue Scale; ST, Sagittal thickness 
  *Independent t-test  
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Table 9.  Mean (SD) of Visual Analogue Scale and Sagittal Thickness by Treatment 
Group over Time 
 Pre 
Mean(SD) 
Post 
Mean(SD) 
p-value* p-value# 
Pre-post 
by-group 
interaction 
VAS      
  Group I (n=22) 7.39 (1.75) 3.43 (1.95)  < 0.001 0.85 0.28 
  Group II (n=22) 6.84 (2.14) 3.55 (1.95)    
ST      
  Group I (n=22) 4.61 (1.19) 3.87 (1.19)   < 0.001 0.23 0.49 
  Group II (n=22) 4.11 (0.99) 3.45 (1.06)    
Abbreviations: SD, Standard deviation; VAS, Visual analog scale; ST, Sagittal thickness. 
* Significant differences between pre- and post-intervention between two groups 
# Significant differences between two groups at post-intervention 
 
 
 
Table 10.  Mean (SD) of Visual Analogue Scale and Sagittal Thickness by Treatment 
Group at Post Intervention (N=44) 
  Group I Mean 
(SD) 
Group II Mean 
(SD) 
   Difference p-value* 
VAS        3.43 (1.95) 3.55 (1.95) - 0.11 0.85 
ST 3.87 (1.19) 3.45 (1.06) 0.40 0.23 
 Abbreviations: SD, Standard deviation; VAS, Visual analog scale; ST, Sagittal thickness. 
*Independent t-test 
 
 
 
At baseline evaluation, no significant differences existed between group I and 
group II with regard to VAS scores, (p = 0.36, Table 8).  The two groups experienced 
improvements in heel pain after completing the assigned treatments compared with 
baseline VAS scores (p < 0.001), but differences between the two groups were small and 
statistically insignificant (p = 0.85, Tables 9,10; Figure 8). 
The results of post intervention evaluation showed that group I managed with 
MPC had improvement and reduction in heel pain of -3.96 scores (95% confidence 
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interval (CI), −4.81 to -3.10) compared to mean reduction of -3.30 scores (95% CI, −4.19 
to -2.40) for group II managed with MPC coupled with plantar fascia SE).  The mean 
difference for heel pain between the two groups was insignificant, mean difference of -
0.11 (95% CI, −1.30 to −1.07; Tables 9, 10) 
 
 
 
 
 
Figure 8.  Mean ± SD of Visual Analogue Scale Scores between the Two Groups over time 
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Figure 9.  Mean ± SD of Visual Analogue Scale Scores by Treatment Group over time 
 
 
 
At baseline evaluation, no significant difference between group I and group II 
with regard to MSK US measurement was detected, (p = 0.14, Table 8; Figure 16) 
The two groups experienced significant reduction in the ST of plantar fascia after 
completing the assigned treatments compared with baseline MSK US measurements (p < 
0.001), but differences between the two groups were insignificant (p = 0.23, Table 9; 
Figures12,16) 
After treatment, group I managed with MPC had a mean reduction  in ST of 
plantar fascia of  -0.74 mm (95% confidence interval (Cl), −0.93to -0.55 mm) compared 
to mean reduction of -0.66 mm (95% CI, −0.80 to −0.51 mm) for   group II managed with 
MPC coupled with plantar fascia SE. (Tables 9, 10). 
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Figure 16. Mean ± SD of Sagittal Thickness by between the Two Groups 
 
 
 
 
Figure 17.  Mean ± SD of Sagittal Thickness by Treatment Group over time 
 
 
 
After treatment, the average reduction in heel pain using VAS as a subjective 
measure was -3.63 ± 1.98 and the average reduction in the ST of plantar fascia using 
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MSK US as an objective outcome measure was -0.70 mm ± 0.37 mm. There was no 
significant correlation between the mean reduction in heel pain scores and the ST of 
proximal insertion of plantar fascia measurement, (r = -0.006, p = 0.97).  
 
Table 11.  Mean (SD) Reduction in Outcome Measures (N=44) 
 Mean (SD) Min, Max 
VAS   -3.63 (1.98) -9.50, -1.00 
ST  -0.70 (0.37) -0.22, 0.00 
Abbreviations: SD, Standard deviation; Min, Minimum; Max, Maximum; Visual Analog Scale VAS; 
Sagittal thickness 
ST,  
 
 
 
 
Figure 18.  Scatter Plot of the Relationship between Average Reduction in Visual 
Analogue Scale and Sagittal Thickness 
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Discussion 
 Plantar fasciitis is one of the most common musculoskeletal conditions seen in 
outpatient orthopedic settings 2,3.  It is associated with morning inferior heel pain 
especially when taking first few steps upon rising 2, 3, 4.  It is further associated with 
abnormal thickening of the proximal plantar fascia.  Many clinical studies found that 
plantar fascia thickening decreased and inferior heel pain improved with the use of 
different nonoperative treatments including steroid injections, nonsteroidal anti-
inflammatory drugs, and Botulinum toxin7,16,17,62,66.    
many research studies has revealed that physical therapy interventions and 
modalities such as  iontophoresis, manual therapy, night splinting, prefabricated and 
customized insets, shoe modification, stretching exercises of calf muscles and plantar 
fascia, taping,  and orthotic devices have proven to be effective in alleviating and 
relieving inferior heel symptoms associated with plantar fasciitis9-11,22,32,33,40-48. 
 In previous physical therapy studies, the effect of the interventions and 
modalities on the treatment of plantar fasciitis was investigated mainly using subjective 
patient reported outcome measures.  Even the psychometric or clinimetric properties of 
those outcomes measures have been documented in the literature63-65,67-72.   It is important 
to employ reliable, valid and responsive objective outcome measures such as ultrasound 
on examining the capacity of new or current physical therapy treatments21,22,37,38,61,62. 
Studies that investigated the effect of nonoperative treatments on plantar fasciitis 
assumed an intimate relationship between the decrease in proximal plantar fascia sagittal 
thickness and inferior heel pain.  While direct correlation was indicated and documented 
when exploring the effectiveness of nonoperative treatments such as the steroid injections 
, the precise relationship between the change in sagittal thicknesses of  plantar fascia and 
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changes in inferior heel pain was not examined when assessing the effectiveness of 
physical therapy interventions or modalities , especially MPC on the treatment of PF.  
The primary focus of this study was to examine if the relationship existed 
between changes in plantar fascia proximal ST of plantar fascia and changes in inferior 
heel pain while evaluating the effectiveness of MPC and MPC coupled with plantar 
fascia SE on the treatment of PF. 
  According to diagnostic sonography studies, PF is considered present when the 
ST of the proximal attachment of the plantar fascia is greater than 4 mm with reduced 
echogenicity, and loss of delineation of the borders of the plantar fascia distal to its 
proximal attachment on the medial tuberosity of the calcaneus11,21,33,73.  
In this study, there were no significant differences in the participants’ 
characteristics  indicated between the two treatment groups in terms of age, gender, 
height, weight, BMI, duration of heel symptoms, athletic status, and involved side. 
Participants’ characteristics in the two treatment groups appeared to be well matched with 
each other and would not affect the VAS and MSK US that have been utilized as 
outcomes measures to determine the effect of MPC on the treatment of PF. 
This prospective clinical trial showed average reduction in inferior heel pain 
scores of -3.6 ± 2.0 and average reduction in the sagittal proximal insertion of thickness 
of plantar fascia of -0.7 mm ± 0.4 mm.  No significant relationship between the change in 
heel pain and the sagittal thickness of proximal insertion of plantar fascia was observed (r 
= -0.006, P = 0.97) , even though this study demonstrated significant statistical reduction 
in inferior heel pain and also in the sagittal thickness of the proximal insertion of plantar 
fascia compared to baseline evaluation.  
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Sometimes the relationship between two variables may be affected by the 
presence of extreme or influential outliers.  The Boxplot is a useful tool in illustrating the 
distribution of data,  and it did not reveal the presence of extreme or influential outliers in 
mean reduction in VAS scores as a subjective outcome measure and MSK US as an 
objective outcome measure.  The convenience sample of 44 participants may not be 
adequate to detect the correlation between self-reported inferior heel pain scores and 
objectively measured proximal sagittal thickness of plantar fascia.  Further studies with 
larger sample sizes of participants is encouraged to be able to infer conclusions about the 
magnitude of the relationship between VAS scores and MSK US measurement when 
examining the effect of MPC on the treatment of PF. 
 
Conclusion 
Using VAS as a subjective outcome measure of inferior heel pain and MSK US as 
an objective outcome measure are vital in assessing the effectiveness of different physical 
therapy interventions and modalities on the treatment of PF. This study showed no 
significant correlation existed between the change in ST of proximal plantar fascia and 
heel pain scores when evaluating the effect of MPC on the treatment PF. However, we 
found significant statistical reduction in the ST measurement of plantar fascia and heel 
pain scores after treatment. 
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CHAPTER FIVE 
DISCUSSION 
 
Plantar fasciitis as a self-limiting condition is the most common cause of inferior 
heel pain. The vast majority of patients experienced resolution of symptoms within 10 
months1,7,19.  The etiology and clinical course of PF is equivocal and still debated among 
medical fraternity7,11,33.   PF is associated with overuse, training errors, improper or worn 
footwear, sudden increase in weight bearing activity, weak intrinsic foot muscles, and 
obesity 8,10,11.  PF appears to be associated with an inflammatory reaction as a result of 
microtears and irritations within the proximal insertion of the plantar fascia. The majority 
of non-operative treatments for PF have demonstrated positive and encouraging results 
but no single treatment is considered best for treating that specific musculoskeletal 
dysfunction 9-11,32,33,40-49.    
Many physical therapy interventions can be utilized to mitigate, alleviate and 
attenuate inferior heel symptoms associated with plantar fasciitis17.  These modalities 
include iontophoresis, manual therapy, night splinting, prefabricated and customized 
insets, shoe modification, stretching exercises for calf muscles and plantar fascia, taping, 
and orthotic devices10,32,40,41,44-48.  
Monophasic pulsed current is utilized clinically to promote wound and pressure 
ulcer healing.  It appears to induce cellular action and histological responses such as 
enhancing production of collagen and deoxyribonucleic acid synthesis, supporting 
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adenosine triphosphate production, as well as increasing the number of growth factor 
receptors and calcium influx52-59.    
The primary focus of this prospective clinical trial was to examine the effect of 
MPC and MPC coupled with plantar fascia SE on heel pain, heel tenderness, functional 
activities level, and ST of plantar fascia on patients diagnosed with PF. No prior studies 
appear to have been conducted in examining the effect of MPC on patients diagnosed 
clinically with PF.  
We hypothesized that the use of monophasic pulsed current would promote and 
accelerate the proximal plantar fascia healing process, especially the proliferation phase 
associated with plantar fasciitis.  Plantar fascia is a connective tissue and the fibroblast 
cells whose main function is to maintain the structural integrity of the plantar fascia.  
Fibroblasts produce collagen, glycosaminoglycans, reticular and elastin fibers, and 
glycoproteins found in the extracellular matrix.  The promotion and acceleration of 
healing processes of the inflamed proximal plantar fascia may decrease heel pain, 
tenderness, improve functional activities level, and reduce abnormal thickening of plantar 
fascia associated with PF.  We utilized plantar fascia SE as demonstrated by DiGiovanni 
in our study because they are considered central to most conservative treatment protocols 
and viable treatment techniques for inferior heel symptoms associated with PF, especially 
in reducing heel pain, heel tenderness and improving functional activities level9. 
The results of this prospective clinical trial were consistent with results of other 
clinical studies which have concluded that physical therapy interventions and modalities 
may alleviate and mitigate inferior heel symptoms and improve patients’s functional 
activities level imposed by plantar fasciitis9-11,32,33,40-49.    
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Data analysis of the of the participants’ characteristics  indicated that no 
significant differences between the two treatment groups in terms of age, sex height, 
weight, BMI, duration of heel symptoms, athletic status, and involved side. Participants’ 
characteristics in the two treatment groups appeared to be generally well matched with 
each other and would not affect the subjective and objective outcome measures utilized to 
determine the effect of MPC on the treatment of PF. 
In post intervention evaluation, both groups indicated statistically significant 
reduction in heel pain compared to baseline evaluation of VAS scores, with a mean effect 
of -3.95 scores on VAS for Group I and -3.29 scores for Group II. The differences 
between the two groups were negligible. The reduction in VAS scores was clinically 
significant61-63.  
Post intervention evaluation revealed significant statistical improvements in heel 
tenderness in both groups.  Group I and Group II displayed a mean effect of 1.9 and 2.0 
kg on the PA scores respectively. However, no significant difference existed between the 
two treatment groups.  This improvement in the PA scores is large enough to be clinically 
important 64-66.  
This study showed significant improvement in functional activities level for both 
groups. Group I and Group II exhibited a mean effect of -18.87 and - 13.09 scores on the 
ADL/ FAAM, respectively. However, no significant difference between the two 
treatment groups was revealed. This reduction in ADL/FAAM scores is large enough to 
be clinically important67-69.     
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Many clinical studies have concluded that plantar fascia thickening has decreased 
and inferior heel pain improved with the use of nonoperative treatments including steroid 
injections, nonsteroidal anti-inflammatory drugs, and Botulinum toxin7,16,17,21-23,38,49,70,71.    
Post intervention evaluation showed that Group I experienced a mean decrease in 
the ST of plantar fascia of -0.7 mm compared to mean reduction of -0.7 mm for   Group 
II. However, no significant difference existed   between the two treatment groups.   
This study revealed a significant decrease in the sagittal thickness of the proximal 
plantar fascia after the use of MPC.   Findings of this clinical trial agreed with previous 
studies about the efficacy of medical treatment options in reducing abnormal proximal 
thickening of planter fascia caused by plantar fasciitis7,16,17,21-23,25,36,38,49,70,71.      
This study further sought to examine whether a statistically significant correlation 
existed between changes in plantar fascia proximal sagittal thickness and changes in 
inferior heel pain while simultaneously evaluating the effectiveness of MPC and MPC 
coupled with plantar fascia SE on the treatment of PF. 
This prospective clinical trial detected an average reduction in inferior heel pain 
of -3.6 ± 1.9 scores and an average reduction in sagittal proximal thickness of the plantar 
fascia of -0.7 mm ± 0.4 mm.  No statistically significant correlation between the mean 
reduction in heel pain and the sagittal thickness of the plantar fascia existed. However, 
this study demonstrated significant statistical reduction in inferior heel pain and in the 
sagittal thickness of the proximal insertion of plantar fascia on patients diagnosed with 
PF compared to baseline evaluation.  
The relationship between two variables may be affected by the presence of 
extreme or influential outliers.  The Boxplot is a useful tool in illustrating the distribution 
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of data,  and it did not reveal the presence of extreme or influential outliers in average 
difference in VAS scores as a subjective outcome measure and MSK US as an objective 
outcome measure. 
The results of this trial need to be viewed in light of two limitations: first, the 
assessor was not blinded to treatment allocation and outcome assessment.  This is a 
potential source of bias. Nevertheless, outcome measures were subjective and self-
reported by participant and MSK US was used as an objective outcome measure.  
Second, more meticulous inclusion and exclusion criteria would be needed to draw sound 
inferences about the effect of MPC. For instance, the participants exhibited chronic 
symptoms with varying duration of symptoms.  Future research should target symptoms 
of a limited duration, i.e., less than 12 months.  
Third, the sample of convenience was insufficiently large, thus we were unable 
infer a more reliable conclusion about the additive effect of plantar fascia SE on the 
treatment of PF. 
The strengths of this study were based on its prospective randomized design. 
Additionally, its attrition rate was not abnormally high.   
Based on this study’s findings, physical therapists are urged to use MPC as an 
effective treatment for patients clinically diagnosed with PF. However, it is suggested 
that physical therapists combine MPC with plantar fascia specific SE to promote and 
accelerate healing processes as well as regaining and maintaining the flexibility of the 
plantar fascia, even though this study did not demonstrate additive effect of using plantar 
fascia SE on inferior heel symptoms caused by PF.  
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Further research is encouraged to address the limitations of this study, issues of 
plantar skin resistance on the treatment with MPC, and the long-term effect of MPC on 
treatment of PF. 
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LETTER FOR PATIENT REFERRAL 
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APPENDIX B 
NEWS PAPERS ADVERTISEMENT 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESEARCH PARTICIPANTS NEEDED  
 
 
The Department of Physical Therapy in the School of Allied Health Professions at 
Loma Linda University is currently conducting a student dissertation project to examine 
the effect of Electrical Stimulation in the treatment of plantar fasciitis (heel pain).  
 
You may qualify to take part in this four week study if: 
 
 You have been diagnosed with PLANTAR FASCIITIS 
 You are at between 18 and 65 years of age 
 
If you are interested in participating or would like further information concerning the 
study, please contact Abdullah Alotaibi at 909-358-3875 or akalotaibi@llu.edu 
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APPENDIX C 
STUDY FLIER 
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APPENDIX D 
AUTHORIZATION FOR USE OF PROTECTED HEALTH 
INFORMATION 
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APPENDIX E 
PATIENT’S INFROMATION FORM 
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APPENDIX F 
PHONE SCRIPT FOR REFERRED PERSONS 
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APPENDIX G 
INFORMED CONSENT FORM 
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APPENDIX H 
CALIFORNIA EXPERIMENTAL SUBJECT’S BILL OF RIGHTS 
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APPENDIX I 
HOME BASED PLANTAR FASCIA STRETCHING EXERCISES 
 
 
 The patient will be instructed to cross the affected leg over the sound leg while 
seated, and using his/her hand, applying metatarso-phalangeal joint dorsiflexion 
(pulling the toes back toward the shin until the patient feels a stretch in the arch of 
the foot). 
  Hold each stretch for a count of 10 (or 10 seconds), and repeating 10 times 
(DONOT OVER STRETCH). 
 All patients will be asked to perform the stretching program three times per day.  
 Keep a daily log of stretching exercise for 4 weeks. 
 The first stretch will be done before taking the first step in the morning. 
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APPENDIX J 
HOME BASED PLANTAR FASCIA STRETCHING EXERCISES LOG 
 
 
Plantar Fascia stretching exercises log 
 
 
Name: ------------------------------------------------- 
 
 
       
Day            
Week 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Week 
1 
       
       
       
Week 
2 
       
       
       
Week 
3 
       
       
       
Week 
4 
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APPENDIX K 
FOOT AND ANKLE ABILITY MEASURE (FAAM) 
ACTIVITIES OF DAILY LIVING SUBSCALE 
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